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Abbreviations
BSCVA  Best spectacle-corrected visual acuity
BSS  Balanced salt solution
C  Celsius
D  Diopters
FDA  (National) Food and drug administration
FFKC  Forme fruste keratoconus
FML  Fluorometholone
FWMH  Full Width at Half Maximum
Hz  Hertz
IOP  Intraocular pressure
IROC  Institute for Refractive and Ophthalmic Surgery
J  Joule
KC  Keratoconus
LASIK  Laser in situ keratomileusis
LKP  Lamellar keratoplasty
mJ  Millijoule
mm  Millimeter
mW  Milliwatt
nm  Nanometer
µm  Micrometer
OSA  Optical Society of America
PKP  Penetrating keratoplasty
PMCD  Pellucidal marginal cormeal degeneration
PRK  Photorefractive keratectomy
PTK  Photorefractive keratotomy
Q factor  Determinand of corneal asphericity
rms  Root-mean-square
rmsh  Root-mean-square of higher order
RST  Residual stromal thickness
SCI  Steep central island
SD  Standard deviation
UCVA  Uncorrected visual acuity
UVA  Ultraviolet A
VA  Visual acuity
W  Watt
X-linking Corneal collagen crosslinking with riboflavin/UVA
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Part 1
Introduction
12
1.1 
Complications in refractive laser surgery
Since the introcduction of the excimer laser in ophthalmology in 1986, refractive 
surgery has seen an enormous increase in the number of procedures. In 2002, the total 
number of refractive laser procedures worldwide has passed the total number of pha-
coemulsification surgery, thus making these procedures the most frequently per-
formed in ophthalmic surgery.
A variety of medical indications exist for this type of surgery such as correction of 
high anisometropia or irregular astigmatism following penetrating keratoplasty, cor-
neal scarring or complicated cataract surgery. However, the most frequent indication is 
the patient’s wish to be independent of spectacles. The term “lifestyle surgery” may be 
applicable to this kind of surgery and due to its cosmetic nature and the financial inter-
est linked to it, many high volume laser centers perform 20’000 or more operations per 
year. Often, these centers do not use state-of the-art equipment and postoperative 
care in some cases (“LASIK tourism”) is only rudimentary.
Therefore, the number of complications has also increased markedly. These compli-
cations may be:
“preoperative” complications due to surgeons inadvertence such as induction of 
keratectasia
intraoperative complications that might either be microceratome-related   
such as cutting errors or laser-related such as decentered ablation, creation of  
small or irregular optical zones and formation of steep central islands
early postoperative complications including diffuse lamellar keratitis, epithelial in-
growth, sterile infiltrates, corneal melting, fungal keratitis and wrinkling syndroma
late postoperative complications including iatrogenic keratectasia, glare and halos 
due to small optical zones and monocular diplopia in decentered ablation or irregular 
astigmatism
13
1.2 Objective and outline
Our work deals with the management and prevention of complications in refractive 
laser surgery. 
Our main contributions to the field are: 
- The development of a new ablation profile for the treatment of steep central islands
- The development of a new surgical technique in automated lamellar keratoplasty
- To demonstrate that corneal collagen cross-linking with riboflavin-UVA can be used  
 to arrest LASIK-induced iatrogenic keratectasia
The main aim of our ongoing work is the application of the UVA cross-linking 
method in patients suffering from corneal irregularities such as progressive keratoko-
nus and pellucid corneal marginal degeneration in order to make these corneas acces-
sible to refractive laser surgery. The aim is not a cosmetic outcome but rather a homo-
genization of the irregular surface so that contact lenses or glasses may be fitted with 
more ease.
14
Part 2 
Management of 
Complications in Refractive 
Laser Surgery
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2.1
Reoperations after LASIK surgery 
16
Abstract
Objective. Reoperations after refractive surgery have increased in frequency during 
the past 10 years. The spectrum of the indications for repeat LASIK may have 
changed. 
Methods. All cases of reoperations after refractive surgery performed between May 
1, 2004 and April 30, 2005 at the Institute of Refractive and Ophthalmic Surgery 
(IROC) were retrospectively investigated regarding indication for repeat surgery and 
visual and refractive results. The 1-month results were used to estimate the refractive 
and visual success rate. 
Results. Of the 76 reoperations, 69 were performed as re-lifts, 3 eyes had new lamel-
lae cut, and 3 cases needed keratoplasty. The reoperations took place 7.5±13 months 
after the primary operation (range 0.5 to 60 months). The most frequent indication 
was residual astigmatism of 0.5 D and more. Visual loss of more than 1 decimal line 
did not occur and unaided visual acuity increased from 0.64 to 1.05. No complica-
tions were reported, however, 3 eyes needed additional enhancement. 
Conclusions. Reoperations after LASIK performed as re-lifts appear to be effective 
and reasonably safe when using the technique described and respecting a residual 
stromal thickness of 280 microns.
Seiler T, Hafezi F, Iseli HP, Koller T, Alkara N.
Klin Monatsbl Augenheilkd 2006; 223:509-512  
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Introduction
Besides a faster visual rehabilitation 
and a minor healing answer, the early 
and uncomplicated reoperation repre-
sents one of the main advantages of the 
laser in situ keratomileusis (LASIK) op-
eration when compared to surface abla-
tion. After initial controversy on whether 
a surface-parallel cut (re-cut) or blunt 
preparation of the primary cut (re-lift) 
should be preferred, 1 today the majority 
of reoperations after LASIK is performed 
using the re-lift variant. 2 
The simplicity of the reoperation as 
well as new individualized ablation algo-
rithms, e.g. wavefront- or topography-
guided, has changed both the spectrum 
and the frequency of reoperations in the 
past years. 2-9 In this work we present 
reoperations that were performed dur-
ing one year at our Institute with special 
emphasis on indication and early post-
operative results.
Patients and Methods
Patients
68 patients that have undergone one 
or more reoperations between may 
2004 and may 2005 in the Institute for 
Refractive and Ophthalmic Surgery 
(IROC) in Zurich, Switzerland, were en-
rolled in this study. This group consisted 
of patients that had primary surgery at 
our Institute (n = 51) and of external 
patients that were either referred to us 
(n = 8) or contacted us spontaneously (n 
= 9). Preoperative investigation included 
slit lamp examination of the anterior 
and posterior segment, autorefractome-
try (Humphrey model 599, Carl Zeiss, 
Jena, Germany) including glare and low-
contrast visual acuity, manual refraction, 
uncorrected and best-corrected visual 
acuity with and without pinhole, corneal 
topography (Keratograph C, Oculus, 
Wetzlar, Germany equipped with To-
polyzer software, Wavelight, Erlangen, 
Germany), aberrometry (Wavefront Ana-
lyzer, Wavelight, Erlangen, Germany), 
applanation tonometry and ultrasound 
pachymetry of the central cornea (SP-
2000, Tomey, Nagoya, Japan). 
In selected cases, the posterior cornea 
was analyzed using a Scheimpflug cam-
era (Pentacam, model 70700, Oculus, 
Wetzlar, Germany). The patient signed a 
consent form after the potential advan-
tages and the risks of the reoperation 
were explained and discussed. In par-
ticular, the potential necessity of a sec-
ond reoperation for fine-tuning of the 
result was emphasized. 
The operative technique
In the majority of cases, blunt dissec-
tion of the primary lamella was per-
2.1 Reoperations
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formed (n = 69). In 3 cases after PRK, 
however, a new lamella was cut. Follow-
ing asymmetrical marking of the cornea, 
the blunt preparation of the lamella was 
performed under the operating micro-
scope of the laser using a special spatula 
(model Vryghem, Moria, France). In a 
next step, the entire lamella was liber-
ated using a conventional iris spatula 
and everted (Calzone technique). Is in all 
cases where the rmsh value for the 
7mm-pupil was 0.6 µm and more (OSA 
notation) and four reliable and consis-
tent measurements with a range of less 
than ±0,1 µm were obtained. 
On the first postoperative day, the 
bandage contact lens was removed and 
slit lamp examination and uncorrected 
visual acuity were performed. Further 
controls took place at 1 month, 3 
months and 1 year after the reoperation. 
Investigations at these times included 
the same examinations as performed 
preoperatively. As a postoperative medi-
cation a combination of antibiotic and 
steroid eye drops was prescribed (Maxi-
trol eye drops, Alcon, Hunenberg, Swit-
zerland) twice to four times daily for two 
weeks, depending on the level of post-
operative inflammation. 
Results
76 reoperations were per-
formed in 68 patients during 
the observational period. 
Deep stroma melting required 
a deep lamellar keratoplasty 
in one case and in two cases, 
automated lamellar kerato-
plasty 12 was performed due 
to a primary cut error with consecutive 
scarring and recurrent epithelial in-
growth. Since these cases required 
longer observation and reoperations, 
they were taken out of the study group. 
In one case with an intraoperative resid-
ual stromal thickness of less than 280 
µm, the reoperation was aborted after 
re-lifting of the flap. Hence, the study 
group contained 64 patients in which 72 
reoperations were performed. Three 
eyes were operated twice (4.2%) and in 
5 patients, both eyes were operated. 
Three post-PRK eyes needed cutting of a 
flap with a microceratome in order to 
perform the reoperation as a LASIK pro-
2.1 Reoperations
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cedure. The other 69 reoperations were 
performed as re-lift procedures with 
blunt preparation of the initial lamella.
The various indications for the re-
LASIK procedures are listed in table 1. 
The by far largest group were eyes in 
which a postoperative astigmatism of 
0.5 D or more was present, followed by 
under- or overcorrection after former 
myopic or hyperopic correction. The 
subgroup with optical inhomogeneities 
included decentered and flattened opti-
cal zones and irregular optical zones of 
unknown origin. LASIK following pene-
trat ing kerato-
p l a s t y r e p r e-
sented another 
small subgroup 
(n=3). In these 
cases, a multi-
step procedure is 
the procedure of 
choice, anyway. 
Reoperations took place at 7,5±13 
months after primary surgery with a 
range from 2 weeks to 60 months. 21 
re a b l a t i o n s we re p e r fo r m e d a s 
wavefront-guided and 7 reablations as 
topography-guided operations. The 
remaining 44 reablations were accom-
plished as Q factor-optimized proce-
dures. All eyes from optical inhomoge-
neities subgroup were wavefront-
guided procedures and three eyes from 
the keratoplasty subgroup were per-
formed as topogra-phy-guided treat-
ments. 
The early postoperative phase was 
inconspicuous in 70 cases. In 2 cases, 
diffuse lamellar keratitis grade 2 re-
quired intensified topical steroid therapy 
for two weeks. At 1 month after surgery, 
32 corneas (44%) showed an epithelial 
ingrowth that was clinically judged as 
monolayered since the epithelium re-
mained optically clear and no signs of 
keratinisation (milky aspect) were de-
tectable. These cases showed no further 
progression at 3 months after surgery 
and thus required no treatment. In the 
subgroup with residual astigmatism, 
refractive astigmatism was reduced from 
0.99±0.76 D (range 0,5 to 3,0 D) to 
0.32±0.35 D at 1 month after surgery. In 
the subgroup consisting of spherical 
under- and overcorrection, all eyes were 
±0.5 D target refraction at one month 
after surgery. 
Uncorrected visual acuity (UCVA), 
seen as a determinant of visual success 
2.1 Reoperations
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of the reoperation, increased from 
0.64±0.24 to 1.05±0.27 in the total pa-
tient population (without intended 
monovision, n = 8). The performance in 
best spectacle-corrected visual acuity 
(BSCVA) is seen as a determinant of the 
safeness of a refractive laser procedure 
and is presented in table 2. For the three 
eyes that underwent two reoperations, 
the last result was included. In the sub-
group suffering from optical inhomoge-
neities, one patient reported persistent 
monocular double vision under mesopic 
conditions even after the second reop-
eration.
Discussion
Hersh and co-workers initially deter-
mined the 10%-incidence of reopera-
tions after LASIK surgery. 2 Our study 
confirms this percentage with 8.5% of 
reoperations following primary surgery. 
This relatively high percentage may 
have several causes. First, the expecta-
tions of the patients have increased 
markedly, not least triggered by aggres-
sive marketing campaigns (lifestyle op-
erations). Second, reoperations per-
formed as LASIK are safer and less com-
plicated than surface retreatments. 
Third, the modern individualized abla-
tion profiles drastically increased the 
success rates of reoperations. Here, not 
only residual aberrations but also the 
aberrations induced by the primary 
treatment 13, 14 can be corrected. 
Over- and undercorrection of astig-
matism still seems to be one of the ma-
jor causes of reoperations after refrac-
tive laser surgery 2, 9, 15-17 with multifac-
tor causes: on one hand, preoperative 
cylinder and axis can be determined 
with less accuracy than the sphere. Fur-
thermore, little is known on the axial 
dependency of corneal asphericity. 18 On 
the other hand, the axis in the reclined 
patient might turn due to cyclotorsion. 
19 We have addressed the latter in our 
patients through preoperative marking 
of the axis in the upright position. Nev-
ertheless, accuracy of astigmatism cor-
rection still remains insufficient. There-
fore, the increased probability of a reop-
eration should be addressed in all pa-
tients with correction of astigmatism 
prior to primary surgery. 
Refractive corrections following pene-
trating or lamellar keratoplasty repre-
sent a special subgroup. Since the LASIK 
cut may alter corneal biomechanics and 
corneal shape, a reoperation is highly 
probable and can be anticipated. Others 
have therefore suggested performing 
just the cut in a first procedure. 20 This 
would enable to correct for the induced 
aberrations in the second procedure. In 
the three cases presented here, the 
2.1 Reoperations
21
topography-guided treatment for the 
homogenization of the optical surface 
was performed along with the LASIK cut 
in a one-step procedure. If necessary, a 
second reoperation must be performed 
within the first two months after the 
initial reoperation due to rapid adher-
ence of the lamella to the transplant 
interface.
The visual changes presented in table 
2 show that re-LASIK is a safe and effi-
cient procedure. Visual loss of more than 
one decimal line is seen as a complica-
tion in refractive laser surgery. 21 In our 
study, no eyes lost more than one deci-
mal line. However, only one-month 
postoperative data were included in this 
study and some late complications 
might alter the results presented here. 
On the other hand, minimal healing 
response and early refractive stability 
represent hallmarks of a LASIK proce-
dure and can be determined with accu-
racy at one month after surgery already.
2.1 Reoperations
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2.2
Customized Ablation Algorithm for the Treatment of 
Steep Central Islands after Refractive Laser Surgery 
23
Abstract
Objective. Steep central island (SCI) formation after photorefractive keratectomy 
(PRK) and laser in situ keratomileusis (LASIK) represents a major drawback in the 
visual rehabilitation of patients after refractive laser surgery. Due to the small size of 
SCI, current ablation algorithms are unable to properly calculate an ablation pattern 
for customized re-treatment. Here we present the use of a new ablation algorithm 
for the treatment of SCI that occurred after PRK or LASIK surgery. 
Methods. Basically, this algorithm uses a smaller zone of approximation and takes 
into account the spherical shift induced by removal of the SCI. 
Results. In all 3 eyes treated, best spectacle-corrected visual acuity increased to 20/
16 and remained stable at the 1 and 3 month follow-up with disappearance of the 
SCI in corneal topography. 
Conclusions. This new treatment algorithm may be of benefit to patients suffering 
from visual side effects due to SCI formation after previous PRK or LASIK surgery.
Hafezi F, Jankov M, Mrochen M, Wullner C, Seiler T.
J Cat Refr Surg 2006; 32:717-721
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Introduction
Nowadays refractive laser surgery of 
the cornea has become a safe and effec-
tive procedure. However, some technical 
advances have only been achieved in 
the past few years and many patients 
treated previously suffer from optical 
complications such as small optical 
zones, decentred ablation and the for-
mation of steep central islands (SCI). 22-27 
Whereas a number of strategies and 
customized treatment techniques have 
been developed to overcome the first 
two issues, 5, 24, 28-31 the latter often re-
mains unresolved with current treat-
ment algorithms.
Recently, attempts were taken to treat 
SCI by topography-guided customized 
treatments. However, current ablation 
algorithms have difficulties to properly 
approximate difference height maps 
due to the small size of the SCI. Here we 
present a new ablation strategy to cor-
rect for SCI after previous photorefrac-
tive keratectomy (PRK) and laser in situ 
keratomileusis (LASIK).
Technique
Definition of steep central    
islands
Definition of diameter and steepening 
of SCI shows variation between authors. 
23, 32-34 We used the definition estab-
lished by Krueger et al. where SCI were 
defined as areas of steepening of at least 
3D and 1.5 mm in diameter. 23
The ablation algorithm
The principle of the new algorithm is 
based on the fact that the surface repre-
sentation of irregular corneas by means 
of an aspheric surface is associated with 
a certain amount of fitting error, espe-
cially in case of spatially localized irregu-
larities. Thus, fitting an asphere to a cor-
neal shape with a SCI and subtracting 
this aspheric fit from the original height 
data, one will be left with a difference 
height map of the SCI that can be used 
for an ablation profile. 
In our study, the data used for deriv-
ing a customized profile for central is-
land treatments were based on corneal 
topography height maps provided by 
the Wavelight Topolyzer System using 
the central 3.5 mm only. The height data 
are fitted to an aspherical shape func-
tion and in a second step subtracted 
from the original data set. The residual 
height information that also includes 
2.2 Steep Central Islands
25
the measured height information of the 
SCI was exported to the Wavelight “eye-
Q” laser system. The required approxi-
mation by means of single laser spots 
(spot diameter 1 mm) was performed 
using a special and adapted version of 
the Wavelight T-CAT program (topo-
graphy-guided customized ablation 
treatment). The proposed ablation pat-
tern was modified adding myopic cor-
rection within the SCI area until a ho-
mogenous ablation pattern with zero 
ablation depth at the edges and the 
height of the SCI as calculated by the 
Munnerlyn’s formula was met (usually 
-0,5 to -1.0 D). Test ablations were per-
fo r m e d o n s p e c i a l te s t t a rg e t s 
(Wavelight Laser Technology) before 
each treatment and visually compared 
to the planned ablation profile. Treat-
ment was performed using a scanning-
spot laser with a 0.8-mm spot size, a 
Gaussian-like spot profile, and a 400-Hz 
repetition rate (Wavelight Allegretto). 
The eye tracking system had a response 
time of fewer than 6 milliseconds. 
Preoperative examinations, 
treatment and postoperative care
Preoperative examination included 
uncorrected (UCVA) and best spectacle-
corrected visual acuity (BSCVA), slit lamp 
examination of the anterior segment, 
fundus examination, corneal topogra-
phy (Topolyzer, Wavelight Laser Tech-
nologie, Erlangen, Germany) and optical 
2.2 Steep Central Islands
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Figure 1. Pre- and postoperative corneal 
topographies (axial representation) and its 
difference map. The preoperative topog-
raphy shows the CSI (A) whereas at one 
day after surgery, the CSI has disappeared 
(B). The difference power map of pre- 
versus postoperative status shows the 
ablation occurred (C).
pachymetry (Pentacam). Treatment was 
performed using the Wavelight Con-
certo laser system (Wavelight Laser 
Technologie, Erlangen, Germany) and 
was performed as LASIK or PRK. In the 
case of Re-LASIK treatment (representa-
tive case reported here), the original flap 
was lifted prior to ablation. At the end of 
treatment, a bandage contact lens was 
applied to the eye, either soaked with 
antibiotic eye drops (LASIK) or antibiotic 
ointment was put on the cornea before 
the bandage contact lens was applied 
(PRK). LASIK: the bandage contact lens 
was removed the next day and the 
cornea was examined for signs of in-
flammation. Dexamethasone eye drops 
were then applied twice daily for 1 
week, followed by a single application 
daily for another week. Postoperative 
follow-ups were performed at 1 day, 1 
month and 3 months after treatment. 
PRK: patients were examined daily for 
closure of corneal epithelium and the 
bandage contact lens was removed at 
day 3 after surgery. After complete clo-
sure of the epithelium, dexamethasone 
eye drops were applied twice daily for 6 
2.2 Steep Central Islands
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Figure 2. Comparison of different ablation patterns. When using a 7mm approximation zone (A), the CSI is signifi-
cantly undertreated. When using a 3.5mm approximation zone without spherical correction (B), again, the CSI is 
not addressed. When adjusting the spherical correction to -0.5D within the 3.5mm approximation zone (C), the CSI 
is fully treated.
weeks. Additional postoperative follow-
ups were performed at 1 month and 3 
months after treatment.
Results
In the past year, we have used this 
technique in a total of three cases. We 
will present the new technique with one 
representative case. The other two pa-
tients were treated accordingly and in 
both cases, UCVA and increased from 
20/60 to 20/16 early and late postopera-
tively.
Representative case
A 47-year-old man was examined in 
November 2004. He had a history of 
previous LASIK in 2003 for Sph: -5.0 
Cyl-0.75 @ 5º on his right eye. Before the 
procedure, best spectacle-corrected 
visual acuity (BSCVA) was 20/16 for the 
right eye. At the time of our first exami-
nation his postoperative UCVA and 
BSCVA was 20/40 with improvement 
with pinhole to 20/20. Corneal topogra-
phy showed a SCI (Fig. 1A) and central 
corneal thicknesses of 500 µm. He re-
2.2 Steep Central Islands
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Figure 3. Standard and customized treatment strate-
gies for the correction of CSI. In previous studies, 
either PTK (A) or PRK (B) ablation modes were used in 
combination of assessment of CSI’s height by the 
Munnerlyn formula. Due to the nature of the ablation 
algorithms, neither a PTK (top-hat) nor a PRK (para-
bolic) algorithm fully correct for the CSI whereas the 
new customized algorithm (C) presented here pro-
vides full CSI correction.
ported glare and halos at night and in-
convenience of vision.
After relifting of the flap, treatment 
was performed as a topography-guided 
LASIK procedure. At the first postopera-
tive day, UCVA was 20/20 and increased 
to 20/16 at 1 month after treatment. At 
the 1 month and 3 month follow-up, 
corneal topography revealed disappear-
ance of the SCI (Fig. 1B). Accordingly, 
glare and halos under mesopic condi-
tions were diminished.
Discussion
A steep central island represents an 
area of localized steepening in the cen-
tral cornea leading to multifocality. 22, 27 
Steep central islands may occur both 
after PRK and LASIK. 1,6 Symptoms in-
clude ghost imaging, halos, glare, night 
driving disability, reduced BSCVA, re-
duced contrast sensitivity and monocu-
lar diplopia leading to slow visual reha-
bilitation. 23, 35 Under experimental con-
ditions, SCI formation has been almost 
exclusively observed after treatment 
with broad beam lasers and rarely with 
scanning slit and flying spot systems. 34
In PRK, steep central islands occur in 
up to 70% of cases at one week after 
treatment. 23 However, they tend to re-
solve with time to an incidence of 2% at 
6 months after surgery. 24, 25 Apparently, 
in PRK, the strong epithelial and stromal 
healing response levels out irregularities 
leading to gradual disappearance of SCI. 
In LASIK, in contrast, SCI formation oc-
curs in only 5 to 12% of cases at 1 week 
after treatment. 25, 32 However, at 6 
months after surgery, typically, three out 
of four steep central islands were still 
present. 25 This might be due to the na-
ture of the LASIK procedure leading to a 
limited epithelial and stromal wound 
healing reaction. 
Although the incidence of SCI forma-
tion is nowadays significantly reduced 
by the use of flying spot laser systems, it 
nevertheless should be regarded as 
important in clinical routine since a large 
number of patients who have been 
t reated with first - and second-
generation laser systems still require 
retreatments for correction.
The nature of SCI formation still re-
mains unclear. In the past, two different 
mechanisms were hypothesized respon-
sible: First, ablation shock waves may 
induce intrastromal shifts of water lead-
ing to different levels of corneal hydra-
tion in the centre and the periphery 36, 37 
and second, the laser beam might be 
blocked centrally by the ejected vortex 
plume of gaseous and particulate debris 
generated during surgery. 23, 32, 38 In 
support of the second hypothesis, Cua 
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and Pepose reported an increased inci-
dence of SCI after LASIK in a laser system 
where the plume evacuator was acci-
dentally installed improperly. 39
To prevent SCI formation, various laser 
systems incorporated anti-steep central 
island programs where a specific over-
correction within the central 25% of the 
ablation zone should compensate for 
the undercorrection. However, results 
were not always satisfactory. 24, 34, 40-42 
Moreover, other attempts were under-
taken to correct steep central islands by 
topography-guided re-treatments using 
topography only as a descriptor of the 
power of the SCI rather than the actual 
height data, still solely relying on Mun-
nerlyn’s formula and a standard PTK or 
PRK formula (Fig. 2). 43 However, current 
algorithms are unable to properly ap-
proximate the difference height map 
due to the small size of steep central 
islands.
We present a new ablation algorithm 
based on the following principle: a pre-
cise corneal topography allows the gen-
eration of a correct height map. The 
difference to the best-fit conoid may 
then be calculated and approximated by 
Zernike polynomials. The 
key point of the technique presented 
here lies in the precision of approxima-
tion, which is dependent on the ablation 
area. Fig. 3A and 3b demonstrate the 
Zernike fit error for different areas of 
approximation. When using the stan-
dard approximation area with a diame-
ter of 7 mm the Zernike fit error is in the 
order of microns, which is close to the 
height of the island itself. In conse-
quence, most of the island would be 
missed using this algorithm (Fig. 3A). 
However, when decreasing the area of 
approximation to 3.5 mm the Zernike fit 
error is in the submicron range (at least 
in the area of interest) (Fig. 3B). Further-
more, the spherical correction must be 
adjusted because removal of the SCI 
includes a spherical shift, which is not 
related to the refraction of the eye 
treated. We adjusted the sphere in a way 
that no tissue is removed at the edges of 
the ablation area (Fig. 3C) and the 
height of the SCI as determined by 
Munnerlyn’s formula is removed. In the 
case presented the refractive height of 
the SCI was 2 diopters and the diameter 
was 2mm. According to Munnerlyn’s 
formula the height was
1/3 x 22 x 3 µm = 4 µm
The peak amount of tissue removed 
equals 3.6 µm, which is close to the 
height calculated. In 1998, Manche et al. 
presented cases of SCI removal using a 
PTK ablation mode and proposed to use 
a PRK mode to improve results. 43 How-
ever, both approaches do not address 
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the true shape of the SCI but match only 
the central amount of tissue removed by 
the height of the SCI (Fig. 3A,B). Usually, 
SCI are not symmetric having a higher 
refractive power in the centre with vari-
able slopes in different meridians. There-
fore, they rather need a customized ab-
lation algorithm as the one presented 
here.
The strategy whether to lift the flap or 
perform a surface ablation clearly de-
pends on the depth of ablation. Scarring 
of the cornea should occur only if Bow-
man’s membrane is penetrated during 
ablation. In cases where the ablation 
depth is larger than 7 to 8 microns we 
suggest to either perform a relift with 
subsequent ablation in the stromal bed 
or to alternatively perform a PRK on the 
flap followed by the application of mi-
tomycin C (2 sponges soaked with mi-
tomycin C 0.02%, 1 minute of action 
each). 
Our approach was to decrease the 
area of approximation in order to more 
accurately treat the SCI. An alternative 
approach would be the use of higher 
orders of approximation higher than the 
sixth order. Since higher order approxi-
mations using Zernike polynomials are 
inconvenient and slowly converting, the 
mathematical alternative would be Fou-
rier or Taylor analysis. Although this ap-
proach has already been used clinically, 
we have not found any scientific and 
peer-reviewed report on this topic. 
In summary, this new ablation algo-
rithm represents a promising step to-
wards the visual rehabilitation of pa-
tients suffering from visual impairment 
due to steep central island formation 
after refractive surgery.
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2.3
Anterior Lamellar Keratoplasty with a Microkera-
tome: a Method for Managing Complications             
after Refractive Surgery 
32
Abstract
Objective. To demonstrate a technique of anterior lamellar keratoplasty (LKP) with 
a standardized and automated preparation of surface-parallel cuts appropriate for 
addressing several problems after LASIK and PRK.
Methods. Noncomparative case series of 10 eyes with complications after LASIK and 
PRK. Lamellar cuts were performed in donor and recipient eyes by means of an 
automated microceratome (Schwind, Kleinostheim, Germany). Lamellar grafts were 
fixed by only 4 single sutures. In two cases, a re-lift LASIK was performed after 6 
months. 
Results. Surgery was uneventful and visual acuity (VA) was improved in all cases. 
Residual irregular astigmatism and refractive error was corrected in two cases by 
means of computer-assist ablation resulting in a further improvement of BCVA and 
unaided VA. 
Conclusions. Anterior lamellar keratoplasty with a microceratome is an easy-to- 
perform procedure and can be used for the management of certain complications of 
PRK and LASIK.
Hafezi F, Mrochen M, Fankhauser F 2nd, Seiler T.
J Refract Surg 2003; 19(1):52-57
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Introduction
To date, keratoplasty following refrac-
tive surgery is a rare procedure when 
compared to the number of corneas 
transplanted after cataract surgery be-
cause of postoperative corneal decom-
pensation. However, in the past few 
years the frequency of refractive surgery 
has increased dramatically and i.e. ex-
ceeded that of cataract surgery in the 
USA by a factor of 2 in 1999. Thus, refrac-
tive surgery will inevitably encounter a 
significant increase of postoperative 
complications in the near future. These 
are located in the anterior cornea and 
include severe scarring after photore-
fractive keratectomy (PRK), cutting er-
rors and recurrent epithelial ingrowth 
after laser in situ keratomileusis (LASIK). 
44, 45
Recently, a new technique for the 
management of such complications was 
presented: therapeutic lamellar kerato-
plasty (LKP) with an automated micro-
ceratome which combines the known 
technique of superficial lamellar kerato-
plasty with the automated preparation 
of the donor lamella and the recipient 
wound bed using microkeratomes 
originally developed for LASIK. 46 Here, 
we present the results of automated 
anterior lamellar keratoplasty in a series 
of 10 eyes that had superficial complica-
tions after refractive laser surgery of 
the cornea. 
Patients and Methods
Patients 
Ten eyes of 10 consecutive patients, 
referred to our department because of 
complications after refractive surgery, 
underwent anterior lamellar kerato-
plasty with a microceratome from Janu-
ary 1999 to July 2000. Four eyes had an 
irregular corneal surface due to cutting 
errors and epithelial ingrowth after LA-
SIK for correction of myopic astigmatism 
(Fig. 1), 4 eyes showed apical scars after 
hyperopic PRK, and 2 eyes displayed 
severe scarring (haze 4) more than 1 
year after myopic PRK. Patient’s age 
ranged from 28 to 51 years with an aver-
age of 34 ± 12 years. 
Due to the multifocality and the tur-
bidity of the corneas only a gross refrac-
tion was possible (Table). To illustrate 
preoperative multifocality a corneal 
topography is shown in Figure 2. In-
formed consent was obtained after a 
thorough explanation of the benefits 
and risks of the operation. Institutional 
review board approval was not required 
for this study.
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Examinations
Preoperatively and at months 1, 3, and 
6 after surgery patients received a stan-
dard ophthalmic examination including 
unaided and best spectacle-corrected 
visual acuity (BCVA), slit lamp inspection, 
indirect fundus examination (with sub-
sequent direct ophthalmoscopy using 
the Goldmann contact lens in the pres-
ence of apparent retinal lesions), appla-
nation tonometry, and corneal topogra-
phy (C-scan, Technomed, Baesweiler, 
Germany). Corneal central and periph-
eral pachymetry (SP-2000, Tomey, Na-
goya, Japan) was performed prior to 
surgery. 
Surgical Management
The basic idea of anterior lamellar 
keratoplasty with a microceratome is to 
create a free cup in the donor and re-
cipient eye using the identical auto-
mated microceratome. The graft is then 
placed on the host wound bed and fixed 
with four temporary and one permanent 
superficial suture in a way that allows a 
re-lift LASIK to be performed to correct 
residual refractive error and irregular 
astigmatism, if needed. 
Preparation of the grafts
The graft was prepared out of the 
whole eye with controlled intraocular 
pressure (IOP). The eye was pressurized 
using a canule inserted through the 
optic nerve connecting the vitreous 
cavity with a water reservoir to achieve 
an IOP of 60 mmHg. Recipient and do-
nor corneas were marked with an 
asymmetric 5 ray-radial marker. Only 
eyes with intact epithelium were used 
for transplantation. 
Particular care was taken to the fol-
lowing points to guarantee constant 
donor corneal disc diameter: in 8 of the 
cases the lamella was prepared by 
means of the Schwind mikrokeratome II 
(Schwind, Kleinostheim, Germany) 
equipped with a special cutting head 
that provides lamellae of a thickness of 
180 ± 26 μm as determined by optical 
pachymetry in pig eyes. Briefly, the cor-
nea was applanated by means of a 
quartz plate, followed by the cut, which 
was performed using a surface-parallel 
sapphire blade. A second suction ring 
fixed the lamella during the cut and cut 
length was adjusted electronically to 
create a free cup. The lamellae had a 
constant diameter of 8.5 mm due to the 
geometry of the applanation area of the 
microkeratome. To achieve constant 
corneal thickness, only corneas from 
donors who died less than 12 hours 
prior to transplantation were used. To 
avoid swelling of the transplant after 
harvesting it was stored in Licorol DX R-
solution (Chauvin, Labege, France) until 
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the recipient wound bed was prepared 
appropriately. 
In the two cases showing cutting er-
rors after LASIK the identical technique 
was used. Here, however, a microcera-
tome of the Cariazzo-Barraquer type 
(Supratome, Schwind, Kleinostheim, 
Germany) was used and the cut was 
completed manually with a blade.
Preparation of the recipient
The recipient cornea was prepared by 
creation of a free surface-parallel lamella 
using the identical marker and auto-
mated microceratome as in the donor 
eye. In the two cases with cutting errors, 
again, the existing cut was completed 
manually. In one case (after hyperopic 
PRK) a lateral canthotomy was per-
formed to obtain sufficient suction. The 
wound bed was cleaned carefully by 
means of a wet sponge and a blunt 
hockey knife and the epithelium was 
stripped back at the cut edges. The 
whole procedure was performed under 
retrobulbar anaesthesia. 
Transplantation 
The graft was placed onto the wound 
bed with the graft’s marks aligned to 
those of the recipient. After two tran-
sient sutures, 4 single superficial sutures 
were placed at 3, 6, 9, and 12 o’clock so 
that tension lines would form a regular 
rhombus. Sutures were placed superfi-
cially in the anterior stroma crossing the 
wound bed only close to the edge. The 
interface was then carefully floated with 
balanced salt solution (BSS) to prevent 
epithelial ingrowth. An additional su-
perficial suture was placed nasally supe-
rior and remained at least 6 months or 
until a decision could be made whether 
a re-lift of the transplant was necessary. 
At the end of the procedure, a bandage 
lens soaked with ofloxacine 0,5% was 
used to decrease postoperative foreign 
body sensation. 
Postoperative Management 
The bandage lens was removed at 
post-op day one and the corneal epithe-
lium was examined by fluorescein stain-
ing. As soon as the epithelium was 
fluorescein-negative the 4 radial sutures 
were removed. Until removal of the su-
tures topical medication included anti-
biotic drops (ofloxacine 0.5%) every two 
hours. After removal of the sutures pa-
tients were instructed to use rimexolol 
drops (Vexol, Alcon, Ft. Worth, Texas) 4 
times a day for two months and tapered 
during post-op months three and four. 
The correction of a residual refractive 
error and the correction of irregular 
astigmatism was undertaken in two 
cases at 6 months after transplantation 
using topography guided LASIK (ORK-
software, Multiscan, Schwind, Kleinos-
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theim, Germany) and a re-lift of the flap. 
At 6 months after automated lamellar 
keratoplasty the manifest refraction as 
well as corneal topography had stabi-
lized.
Results
Surgery went uneventful in all 10 
eyes. In two eyes, the graft epithelium 
was loose and oedematous and was 
removed during the operation. At day 1 
after surgery, the graft was swollen with 
prominent edges in all cases. The 4 su-
tures were removed after healing of the 
epithelium and clarification of the la-
mella, which occurred within 6 days in 
all eyes. In no case additional sutures 
were necessary. Eight cases displayed 
residual donor epithelium healing lines 
at months 1 and 3, which were inter-
preted as epithelial rejection lines. In 7 
of the 10 eyes a central steepening was 
apparent at months 1 and 3 that de-
creased within 6 months after surgery. In 
one case at three months after surgery a 
sterile infiltrate occurred in the interface 
that healed under topical corticoid ther-
apy within a week.
Visual results are listed in Table 1. Vis-
ual acuity recovered within the first 
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Figure 1. Treatment of a cutting error and epithelial 
ingrowth after LASIK for correction of myopic astigma-
tism. Cornea 3 weeks after LASIK with an irregular edge of 
the lamella and severe epithelial ingrowth (upper right). 1 
week after anterior LKP with a microceratome; sutures 
were removed on day 5 after surgery (right). Corneal 
topography 1 month after automated LKP. Visual acuity 
was 20/30, 0.4p with a refraction of +1.0 cyl – 0.5/60° 
(lower left).
month after surgery but BCVA was lim-
ited by the multifocal cornea. Visual 
rehabilitation to a BCVA of 20/40 or bet-
ter was achieved in 7 of the 10 eyes. On 
average, BCVA improved from 20/200 ± 
20/200 to 20/40 ± 20/100 (p< 0.05). 
A typical example is described in the 
following case report:
A 42-year-old female patient received 
bilateral simultaneous LASIK for myopic 
astigmatism in a local laser centre. Pre-
operative BCVA was 20/20 OU. Accord-
ing to the operation report a cutting 
error occurred in the left eye. The flap 
had an irregular form and was incom-
plete. After manual flap completion a 3.5 
D laser treatment for correction of myo-
pia was performed. Postoperative BCVA 
was never better than 20/100 and when 
the patient was referred to our depart-
ment on post-op day 21 visual acuity 
was counting fingers. The flap was oe-
dematous and epithelial ingrowth had 
led to melting of the flap (Fig. 1). We 
removed the primary flap by completing 
the original cut, cleaned the wound bed 
carefully by means of a hockey knife, 
and performed an anterior lamellar kera-
toplasty with a microceratome. 
After removal of the 4 sutures BCVA 
was 20/100 and improved to 20/60 at 1 
month and 20/30 at month 3 after kera-
toplasty. BCVA did not improve further 
and a topography-guided laser treat-
ment was performed at month 6 includ-
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Figure 2. Treatment of cornea after hyperopic HO:YAG 
laser-thermokeratoplasty and hyperopic PRK. The apical 
scar occurred 2 months after hyperopic PRK and two 
attempts to remove the scar by phototherapeutic keratec-
tomy and manual scraping failed (upper left). Preoperative 
corneal topography (upper right). One month after ante-
rior LKP with a microceratome visual acuity was 20/50 with 
a refraction of + 5.0 sph (lower left).
ing an uncomplicated re-lift of the flap. 
One month after this re-operation un-
aided VA was 20/25 (+1). 
A second case demonstrates the ef-
fect of automated LKP in a cornea after 
hyperopic HO:YAG laserthermokerato-
plasty and hyperopic PRK where all pre-
vious attempts to remove the apical scar 
failed (Fig. 2). Here, BCVA increased from 
20/100 preoperatively to 20/50 one 
month postoperatively.
Discussion
The key findings of this study are that 
in cases with visually significant compli-
cations after lamellar refractive surgery 
automated LKP led, within a reasonable 
rehabilitation time, to a visual acuity of 
20/40 in 70% of the cases. Further im-
provement might be obtained by re-
operations using computer-assist abla-
tion (topography- or wavefront-guided).
By the midst of the last century ante-
rior LKP was a popular and frequently 
used method in corneal surgery. How-
ever, in the 1960s anterior LKP was sub-
sequently replaced by PKP. This ten-
dency was accelerated by the growing 
knowledge of the molecular events 
leading to graft rejection and the devel-
opment of improved surgical instrumen-
tation and techniques. 47
LASIK and PRK, however, are lamellar 
techniques and therefore the majority of 
problems after refractive surgery occur 
at the anterior surface of the cornea: 
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scarring after PRK, cutting errors during 
LASIK and recurrent epithelial ingrowth 
after LASIK with melting of the flap. 44, 45 
In some cases, those conditions cannot 
be managed other than by keratoplasty. 
We suggest that in these cases LKP 
rather than PKP should be envisaged for 
the following reasons: 48 First, the cor-
neal endothelium is not transplanted 
resulting in fewer rejections and less 
rigid selection criteria for donor mate-
rial. Second, anterior LKP is less invasive 
than PKP thus reducing complications. 
In the case of iatrogenic keratectasia 
however, where the biomechanical sta-
bility of the residual stroma is insuffi-
cient for anterior LKP, penetrating kera-
toplasty until recently represented the 
technique of choice. A new alternative 
way to manage iatrogenic keratectasia 
may be deep lamellar keratoplasty 
where a significant part of the corneal 
stroma is replaced by donor stroma 
while the recipient’s endothelium and 
Descemet’s membrane are still pre-
served. 49
Until recently, lamellar keratoplasty 
was technically difficult to perform and 
optical rehabilitation, one of the main 
goals, was not always achieved. Fur-
thermore, the manual preparation of the 
lamellae (donor and recipient) often 
caused irregularities of the interface 
with subsequent consequences on 
postoperative healing and vision. The 
approach presented here, inaugurated 
recently and independently from us, 
may help to overcome these problems 
since the manual preparation of the 
surface-parallel cuts is markedly im-
proved by a standardized technique and 
reproducible thickness of donor and 
recipient lamellae is achieved. This stan-
dardization significantly shortens post-
operative rehabilitation by allowing 
suture removal already after a few days. 
Another advantage of automated LKP 
in the management of complications 
after refractive surgery is the possibility 
of a re-treatment by lifting the flap to 
correct for any residual refractive error 
or irregular astigmatism reducing the 
patient’s visual acuity. Here the remain-
ing superficial suture serves as an artifi-
cial hinch allowing a re-lift of the flap 
similar to the re-lift performed in re-
LASIK. 
Although the superficial suture might 
induce some degree of corneal astigma-
tism we believe that its function as a 
hinch is more important for the proce-
dure than its astigma-tism-inducing 
effect. The additional laser ablation may 
be performed as topo-graphy-guided 
ablation in gross irregularities or as 
wavefront-guided ablation for fine-
tuning of corneal optics. 31 The two re-
lifts performed at 6 months after surgery 
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were uneventful and resulted in an im-
provement in best spectacle-corrected 
visual acuity to 20/30 in both cases. 
In summary, we suggest that anterior 
LKP with a microceratome may be used 
for surface problems of the cornea and 
particularly problems after LASIK and 
PRK: the procedure is easy to perform 
using the same cutting technique as for 
LASIK. Furthermore, sutures can be re-
moved after a few days and later refrac-
tive reoperations open further alleys for 
visual rehabilitation. In this small series 
we have not encountered problematic 
rejections of transplanted lamellae. 
However, such rejections have been 
reported elsewhere to be rare. Therefore, 
longer follow-up and a larger number of 
cases are required to estimate the effec-
tive clinical value of this procedure.
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2.4
Two-step Procedure to Enlarge Small Optical Zones 
after Photorefractive Keratectomy for High Myopia 
42
Abstract
Objective. Here we describe a method for the visual rehabilitation of patients suffer-
ing from small optical zones and related complaints after photorefractive keratec-
tomy (PRK) and laser in situ keratomileusis (LASIK) for high myopia. In many of these 
cases that occurred in the early 1990s, low central corneal thickness in combination 
with residual myopia does not allow for enlargement of the small optical zone by a 
topography-guided treatment in the first instance.
Methods. In a first step, a clear lens exchange is performed aiming at hyperopia. 
This enables us to perform in a second step a topography-guided customized PRK 
with marked enlargement of the optical zone.
Results. At 3 months after surgery, the optical zone is usually enlarged by 2 to 3 mm 
with massive reduction of preoperative visual symptoms under mesopic conditions.
Conclusions. Such two-step procedures may be of distinct benefit to patients suffer-
ing from small optical zones and low central corneal thickness.
Hafezi F, Mrochen M, Seiler T.
J Cataract Refract Surg 2005; 31:2254-2256
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Introduction
In the early and mid 1990s photore-
fractive keratectomy (PRK) for myopia of 
more than -7.0 D sphere was a fre-
quently performed procedure. 50 By that 
time, relatively little was known about 
corneal wound healing and the proce-
dures often led to corneal scarring, de-
centered ablations, regression and, in 
the case of excessive surface ablation, 
even to iatrogenic central keratectasia. 
51, 52  Even if none of the above men-
tioned complications occurred, the 
treatment was associated with small 
optical zones with resulting halos and 
glare under mesopic conditions and 
even monocular diplopia. 53, 54 Many of 
these former refractive patients seek 
help in recently developed techniques 
such as customized ablations. 29 How-
ever, many of these cases show residual 
myopia combined with critically low 
central corneal thickness. Here, a pri-
mary topography-guided treat-ment to 
enlarge the optical zone is obsolete 
because of distinct keratectasia risk (Fig. 
1). 51, 52 
We have therefore developed a 2-step 
procedure for the treatment of such 
cases: in a first step, a clear lens ex-
change shifts the patient to hyperopia. 
Calculation of a topography-based abla-
tion profile now shows that ablation in 
the centre of the cornea is minimal (Fig. 
2), thus enabling the customized 
topography-guided treatment (Fig. 3). 
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Figure 1. Ablation profile approxi-
mated by Zernike polynomials 
based on topographies taken 
before any procedure was under-
taken. Enlargement of the optical 
zone cannot be performed because 
residual central corneal thickness 
would be dangerously low.
Technique
In the past two years, we have used 
this technique in a total of 5 patients. 
Here, the proceeding is demonstrated in 
the case of a 41-year-old man who was 
examined in October 2003. He had a 
history of previous PRK in 1996 for -9.0 D 
sphere on both eyes. Uncorrected visual 
acuity (UCVA) was 0.5 for the right eye 
and 0.7 for the left eye. Best spectacle 
corrected visual acuity (BSCVA) was 0.8 
for both eyes with -1.0 D sphere. Corneal 
topographies (axial representation) 
showed bilateral small optical zones of 
approximately 2mm (right eye, Fig. 3A) 
and central corneal thicknesses of 280 
(right eye) and 270 (left eye) µm, respec-
tively. He reported massive glare and 
halos under mesopic conditions (pupil 
size ≥5mm), especially on the right eye. 
Symptoms were more pronounced on 
the right eye and we decided to first 
treat the right eye until the patient’s 
symptoms would improve markedly. 
Central corneal pachymetry was 280 µm 
and prohibited further central ablation. 
Enlarging the optical zone even refrac-
tively neutral would require a central 
(PTK) ablation thus further thinning the 
cornea centrally (Fig. 1). 
Based on corneal topography we cal-
culated the ablation pattern (T-Cat soft-
ware, Wavelight Technologies, Erlangen, 
Germany) for expanding the optical 
zone to a diameter of 5 to 6 mm. We 
then optimized the spherical part of the 
ablation so that the central keratectomy 
depth was zero, which happened at a 
spherical correction of +2.0D. Therefore, 
we performed a clear lens exchange in 
this pre-presbyopic patient with in-
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Figure 2. Ablation profile approximated 
by Zernike polynomials based on topog-
raphies taken after a clear lens exchange 
(same patient as figure1). Now, the 
ablation profile focuses on the periph-
eral cornea whereas central corneal 
thickness remains unchanged.
tended hyperopia of +2.0D. Inclusion 
criteria for the clear lens exchange in 
this patient were his age (pre -
presbyopic) and the absence of stromal 
scars as a complication of the former 
surface ablation. We used Haigis formula 
for calculation of the refractive power of 
the IOL7 and implanted an ACRYSOF© 
Lens (Alcon, Ft. Worth/TX, USA). 
At 2 months after the first procedure, 
UCVA was 0.4 and BSCVA was 0.8 with 
+2.75 D sphere. Again, ablation profiles 
were calculated now leaving the central 
cornea unaltered (Fig. 2). 6 months later, 
we performed a PRK for correction of 
hyperopia and enlargement of the opti-
cal zone. 3 months later, UCVA was 0.8. 
Zernike analysis of the pre- and postop-
erative corneal topographies revealed 
virtually identical coma-like aberrations, 
however an improvement in spherical 
aberrations by a factor of 2.7 and ac-
cordingly, halos and glare were mas-
sively reduced. The optical zone was 
distinctly enlarged from 2 mm before 
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Figure 3. Topographies (axial representation) taken 
before (A) and at 3 months after (B) the 2 step-
procedure. A significant enlargement of the optical 
zone from 2 mm to 5 to 6 mm was achieved despite 
low central corneal thickness.
the 2-step procedure to 5 to 6 mm (Fig. 
3A,B).
Discussion
Topography-guided customized PRK 
has been repeatedly used for the en-
largement of small optical zones after 
initial PRK for high myopia. 29 However, 
small optical zones with low residual 
corneal thicknesses are a frequently 
encountered entity after PRK for high 
myopia in the early and mid 1990s. 50 
Here, the risk of induction of postopera-
tive keratectasia 52, 55 often prohibits any 
further central ablation or does not al-
low for full spherical correction. 
This dilemma may be solved by first 
performing a clear lens exchange thus 
shifting the patient to hyperopia. The 
second step in visual rehabilitation is a 
customized topography-guided PRK 
treatment for hyperopia ablating the 
peripheral cornea where sufficient cor-
neal thickness is still present. 
In such way, enlargement of the opti-
cal zone up to 7 mm of diameter is pos-
sible. Such 2-step-proce-dures may be of 
general benefit in the visual rehabilita-
tion of presbyopic patients suffering 
from small optical zones in the absence 
of corneal scars after PRK for high myo-
pia.
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Abstract
Objective. Corneal collagen cross-linking by UVA/riboflavin (X-linking) represents a 
new method for the treatment of progressive keratoconus and currently is under 
clinical investigation. In order to avoid UVA irradiation damage to the corneal endo-
thelium, the parameters for X-linking are set in a way that effective treatment only 
occurs in the first 300 µm of the corneal stroma. Here, X-linking not only strengthens 
the biomechanical properties of the cornea but also induces keratocyte apoptosis. 
To date, the effectiveness of treatment could only be monitored indirectly by postop-
erative follow-up corneal topographies or using corneal confocal microscopy. Here 
we describe a corneal stromal demarcation line indicating the transition zone be-
tween crosslinked anterior corneal stroma and untreated posterior corneal stroma. 
The demarcation line is biomicroscopically detectable in slit lamp examination as 
early as 2 weeks after treatment.
Methods. X-linking was performed in sixteen cases of progressive keratoconus and 
corneas were examined biomicroscopically and by means of corneal topography 
and pachymetry before and after treatment.
Results. In 14 of 16 cases a thin stromal demarcation line was visible at a depth of 
approximately 300µm over the whole cornea following X-linking treatment.
Conclusions. This newly observed demarcation line may result from differences in 
the refractive index and/or reflection properties of untreated versus X-linked corneal 
stroma and represents an effective tool to biomicroscopically easily monitor the 
depth of effective X-linking-treatment in keratoconus.
Seiler T, Hafezi F.
Cornea 2006;25:1057-1059
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Introduction
Keratoconus represents a disorder of 
the corneal stroma that is associated 
with decreased biomechanical strength 
of the tissue, probably due to dimin-
ished intra- and interfibrillar crosslinks of 
the collagen fibers. 56 Recently, a new 
method has been developed for the 
treatment of progressive keratoconus, 
which currently is under clinical investi-
gation: corneal collagen cross-linking 
with riboflavin/UVA (X-linking). 57, 58 
Here, additional crosslinks are formed 
using UVA and riboflavin as a chromo-
phore. The method has been studied 
extensively in various animal models for 
years 57, 59-61 and was successfully ap-
plied in a phase 1 clinical trial for pro-
gressive keratoconus in humans. 62 Basi-
cally, X-linking treatment markedly stiff-
ens the cornea and increases the biome-
chanical strength by a factor 1.4 in vivo 
in rabbit corneas and by a factor 4.5 ex 
vivo in human corneas. 57, 63 To avoid 
potential irradiation damage to the cor-
neal endothelium by UVA light, the 
technical parameters are set in a way 
that only the anterior 300 µm of corneal 
stroma are treated. 
To date, the transition zone between 
X-linked and untreated corneal stroma 
could only be visualized using corneal 
confocal microscopy. 64 
Here we report biomicroscopical iden-
tification of a corneal stromal demarca-
tion line that corresponds to this transi-
tion zone.
Materials and Methods
Inclusion criteria
16 patients suffering from progressive 
keratoconus (age range 18 to 39 years, 
mean age 26.4 years) with maximal cor-
neal K readings of 60 D and central cor-
neal thickness of at least 400 µm were 
treated by corneal collagen X-linking 
with riboflavin/UVA. Inclusion criteria 
were the identification of progressive 
keratectasia in corneal topographies 
using both the Schwiegerling Z3 coeffi-
cient 65 and an increase of maximal K-
readings in several consecutive record-
ings over a period of up to 6 months, 
along with anamnestically reported 
deterioration of vision. Preoperative as 
well as postoperative examination in-
cluded slit lamp examination, best 
spectacle -corrected visual acuity 
(BSCVA), corneal topography as well as a 
pachymetry map (Pentacam, Oculus 
Instruments, Wetzlar, Germany) and 
applanation tonometry.
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Preparation of 0.1% 
riboflavin solution
Dilute Vitamin B2-r iboflavin-5-
phosphate 0.5% (G. Streuli & Co. AG, 
Uznach, Switzerland) with dextran T500 
(Roth AG, Karlsruhe, Germany) to 
achieve a 0.1% Riboflavin solution. The 
solution was protected from light and 
used within 24 hours.
Corneal collagen riboflavin/UVA-
cross-linking (X-linking)
The procedure was performed as de-
scribed previously. 62 Briefly, topical an-
aesthesia was applied prior to the pro-
cedure using tetracaine 1% and oxy-
buprocaine 0.4% eye drops (Novartis 
Pharma, Bern, Switzerland). The corneal 
epithelium was mechanically removed 
with a diameter of 6 mm using a blunt 
knife and riboflavin 0.1% solution was 
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FIGURE 1. Corneal demarcation line after X-linking. A, Regular aspect of the cornea at 2 weeks after X-linking (top 
left). B, The demarcation line (arrows) lies in a depth of approximately 300µm. The conical shape of the line is 
explained by the increasing thickness of the cornea in the periphery. C, In the central cornea, the line (arrows) can 
be identified at approximately 60% corneal depth. D, In the (thicker) periphery the line (arrow) lies at approxi-
mately 30-40%.
instilled repeatedly for approximately 20 
minutes. Penetration of the cornea and 
presence of riboflavin in the anterior 
chamber (riboflavin shielding) was 
monitored with slit lamp examination. 
UVA irradiation was performed using an 
optical system (Köhler illumination) with 
a light source consisting of an array of 7 
UV diodes (365 nm; Nichia, Nuernberg, 
Germany) with a potentiometer in series 
to allow for regulation of voltage. Prior 
to treatment, intended irradiance of 3 
mW/cm2 surface irradiance (5.4 J/cm2 
surface dose) was calibrated using a UVA 
meter (LaserMate-Q; LASER 2000, 
Wessling, Germany) at a working dis-
tance of 1 cm. Irradiance was performed 
for 30 minutes using 3 mW/cm2, corre-
sponding to a dose of 5.4 J/cm2. 
During treatment, riboflavin solution 
was applied every 5 minutes to saturate 
the cornea with riboflavin and drops of 
physiological salt solution were applied 
every 2 minutes to moisten the cornea. 
After the treatment, a bandage contact 
lens soaked with preservative free anti-
biotic (Ofloxacin) was applied until 
complete closure of the corneal epithe-
lium, followed by application of fluoro-
metholon eye drops twice daily for 6 
weeks.
Results
Postoperative healing was uneventful 
in all cases. In accordance to previously 
published data, 62 we detected no side 
effects of the anterior or posterior seg-
ment: in particular, corneal endothelium 
showed no signs of cytotoxic damage 
and lens transparency and intraocular 
pressure remained unchanged.
However, in 14 out of 16 patients, we 
identified a demarcation line in the deep 
corneal stroma detectable by slit lamp 
examination (Fig. 1). In the central cor-
neal stroma, the line can be identified at 
approximately 60% corneal depth (Fig. 
1B,C). The line is best identified with a 
thin slit and high illumination levels 
using a slit lamp that provides high lev-
els of white light. In the corneal periph-
ery the line gradually adapts a conical 
shape due to the increasing total cor-
neal thickness (Fig. 1D). The line be-
comes visible as early as 2 weeks after 
treatment and was not present prior to 
treatment (n=16).
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Discussion
When treating patients with corneal 
X-linking, special emphasis has to be 
taken to ensure protection of the cor-
neal endothelium from potential UVA 
irradiation damage. The stromal depth 
of effective X-linking treatment depends 
on the concentration of riboflavin solu-
tion and the intensity of UVA light. The 
ideal riboflavin concentration and UVA 
intensity levels were identified through 
dose/concentration essays in vitro and 
in various animal models. 57-59, 61, 66-68 
The parameters currently used in hu-
mans (international multicenter clinical 
phase 2 study monitored by us) are 0.1% 
riboflavin solution and 3 mW/cm2 of 
UVA. It has been shown unambiguously 
that at these settings the effect of X-
linking is limited to the anterior 300µm 
of the cornea. 60 Furthermore, only pa-
tients with a central corneal thickness of 
at least 400 µm are subjected to this 
treatment.
Besides induction of additional 
crosslinks between collagen fibers, the 
X-linking treatment induces various 
other stromal changes: Wollensak and 
colleagues have shown induction of 
keratocyte apoptosis in the rabbit cor-
nea following cross-linking treatment. 60 
However, corneal transparency and 
thickness remained unchanged and 
keratocyte apoptosis also occurs fol-
lowing PRK, LASIK and even corneal 
abrasion. 69
In consequence, following X-linking 
treatment one should differentiate be-
tween the treated anterior corneal stro-
ma and the untreated posterior corneal 
stroma. The positive effect of corneal X-
linking on corneal biomechanics can be 
monitored indirectly using corneal to-
pography. However, until recently, there 
was no method available to directly 
monitor the effect of corneal X-linking 
on the anterior corneal stroma.
In a recent study, Caporossi’s group 
has performed confocal microscopy 
analyses in humans following X-linking. 
64 Interestingly, they in vivo detected the 
effective depth of treatment by identify-
ing distinct vertical and lateral transition 
areas at a depth of 270 to 330µm. Here, 
the anterior (treated) stroma showed 
oedema with only few keratocyte nuclei 
and poor reflectivity whereas the poste-
rior (untreated) stroma showed regular 
keratocyte population and normal re-
flectivity. Keratocyte repopulation of the 
treated stroma started at 1 month after 
treatment and was completed at 6 
months after treatment. Corneal endo-
thelium showed regular morphology up 
to 6 months after treatment.
In accordance with these findings, we 
here report identification of a corneal 
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stromal demarcation line that becomes 
visible at 2 weeks after X-linking treat-
ment in a depth of approximately 300 
µm. To our knowledge, presence of such 
a demarcation line following X-linking 
has not been reported to date and ulti-
mately implies either a change in the 
refractive index and/or reflection prop-
erties of treated versus untreated cor-
nea. Based on the findings by Caporossi 
et al. 64 we suggest that this line actually 
represents the demarcation line be-
tween crosslinked und untreated cor-
nea. 
The demarcation line described here 
represents, besides corneal topography, 
a direct clinical sign to detect the effect 
of X-linking in the cornea and, in addi-
tion, may help to clinically estimate the 
thickness of the stromal layer that un-
derwent X-linking.
In conclusion, biomiscroscopic identi-
fication of this line represents a simple 
and effective clinical tool to easily moni-
tor the effective depth of X-linking 
treatment.
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2.6
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Abstract
Objective. Iatrogenic keratectasia after laser in situ keratomileusis (LASIK) repre-
sents a major complication in refractive surgery. To date, rigid contact lenses, pene-
trating keratoplasty or Intacs were the only therapeutic option in many of these 
cases. In this study, riboflavin/UVA corneal cross-linking (X-linking) was investigated 
to decide whether it represents an alternative therapeutic means to prevent keratec-
tasia progression.
Methods. Corneal X-linking was performed in eight patients with a formerly undi-
agnosed forme fruste keratoconus or pellucidal marginal corneal degeneration that 
underwent LASIK for myopic astigmatism and subsequently developed iatrogenic 
keratectasia. The postoperative follow-up ranged from 7 to 20 months.
Results. UV-induced X-linking led to an arrest of keratectasia progression over a 
postoperative follow-up period of up to 20 months as demonstrated by stable pre- 
and postoperative corneal topography and reduction of maximal K readings.
Conclusions. Riboflavin/UVA corneal cross-linking increases the biomechanical 
stability of the cornea and may thus be a therapeutic means to slow down, arrest 
and even partially reverse the progression of LASIK-induced iatrogenic keratectasia.
Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T.
J Cat Refract Surg. 2007. 33(12):2035-40
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Introduction
Since its first description in 1998 ia-
trogenic keratectasia induced by laser in 
situ keratomileusis (LASIK) was quickly 
recognized as one of the major compli-
cations in corneal refractive laser sur-
gery. 55, 70 Affected eyes show progres-
sive central or inferior corneal steepen-
ing associated with stromal thinning 
and significant changes of the refractive 
error. The major risk factors for the in-
duction of keratectasia after LASIK sur-
gery are low residual stromal thickness 
(RST), re-treatments and pre-existing 
abnormal corneal topography (for re-
view see 71, 72). Until lately, treatment 
options were limited: aside from rigid 
contact lenses, some reports indicate 
that insertion of Intacs might help to 
mechanically stabilize the cornea. 73-75 
However, long-term results of this 
method are not available yet and most 
cases are nowadays treated by penetrat-
ing keratoplasty. 76
Riboflavin/UVA-induced cross-linking 
of corneal collagen (X-linking) is a new 
method to increase the biomechanical 
stability of the cornea by the induction 
of additional crosslinks between or 
within collagen fibers using UVA light 
and riboflavin as a photomediator. 58 Its 
therapeutic potential has been demon-
strated in a clinical phase I study for the 
treatment of progressive keratoconus. 62
Recently, Kohlhaas et al. reported a 
case of iatrogenic keratectasia after LA-
SIK that was successfully treated by X-
linking. 77 Here, we report successful 
application of this new method in a se-
ries of cases with a follow-up period of 
up to 20 months.
Methods
Surgical technique
The procedure was performed simi-
larly as described previously. 62 After 
topical anaesthesia with tetracaine 1% 
and 0.4% oxybuprocaine eye drops, the 
corneal epithelium was mechanically 
removed within a diameter of 6 to 8 
mm, followed by application of ribofla-
vin (0.1% solution 10 mg riboflavin-5-
phosphate in 10 ml dextran-T-500 20% 
solution) every 3 minutes for approxi-
mately 30 minutes until complete pene-
tration of the stroma and yellow staining 
of the aqueous (riboflavin shielding). 
UVA irradiation was performed for an-
other 30 minutes with an irradiance of 
3mW/cm2 (total dose density 5.4 mJ/
cm2) Prior to treatment; the irradiance 
was calibrated using a UVA meter 
(LaserMate-Q; LASER 2000, Wessling, 
Germany) at a working distance of 3 cm. 
During treatment, riboflavin solution 
was applied every 5 minutes to saturate 
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the cornea with riboflavin and drops of 
balanced salt solution were applied 
every 2 minutes to moisten the cornea. 
After the treatment, a bandage contact 
lens soaked with preservative free anti-
biotic (Ofloxacin) was applied until 
complete healing of the corneal epithe-
lium, followed by application of fluoro-
metholon eye drops twice daily for 6 
weeks.
Preoperative as well as postoperative 
examination included slit lamp examina-
tion, best spectacle-corrected visual 
acuity (BSCVA), BSCVA with pinhole, 
corneal topography as well as Scheimp-
flug scanning including corneal thick-
ness (Pentacam, Oculus Instruments, 
Wetzlar, Germany) and applanation to-
nometry. Inclusion criteria were the 
verification of progressive keratectasia in 
corneal topographies us ing the 
Schwiegerling Z3 coefficient 65 and in-
crease of maximal K-readings in several 
consecutive recordings over a period of 
up to 6 months, a minimal corneal thick-
ness of at least 400 µm and anamnesti-
cally reported changes in refraction.
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Figure 1. Time course of corneal topographies (axial representation) A: before LASIK surgery. B: At 10 months after 
LASIK surgery. C: At 13 months after LASIK surgery, one day before UV/riboflavin-induced cross-linking. D: At 20 
months after cross-linking, the maximal steepening of the inferior cornea decreased distinctly.
Results
Table 1 summarizes the preoperative 
and postoperative findings in all pa-
tients with iatrogenic keratectasia fol-
lowing LASIK surgery that were treated 
by X-linking: in 7 of these cases, formerly 
undiagnosed forme fruste keratoconus 
(FFKC) was the reason for the biome-
chanical instability following LASIK, in 
one case the underlying reason was 
undiagnosed pellucidal marginal cor-
neal degeneration (PMCD) and in one 
other case we could not identify a rea-
son. Surgery as well as the postoperative 
period was uneventful in all cases with 
one exception where endothelial irregu-
larity and some opacity on the endothe-
lial level were noted. The endothelium 
cleared up with a normal cell count 
(2350 cells/mm2) at 9 months after X-
linking. In all cases, progression of ker-
atectasia was arrested and reduction of 
postoperative cylinder was noted. 
Case 1:
 LASIK with consecutive iatrogenic 
keratectasia in preoperatively unrec-
ognized forme fruste or slowly pro-
gressive pellucidal marginal corneal 
degeneration (PMCD) 
A 32-year-old male patient presented 
in 2004 with a history of previous LASIK 
surgery on the left eye for myopic 
astigmatism in April 2003. Initially, cen-
tral corneal pachymetry was 617 µm for 
the left eye, uncorrected visual acuity 
(UCVA) was 20/60 and best spectacle-
corrected visual acuity (BSCVA) was 20/
16 with -2.5cyl-0.75/82º. Corneal topog-
raphy (axial representation) showed 
signs of a forme fruste PMCD that was 
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Figure 2. Following initial LASIK surgery, 
induced keratectasia occurred with pro-
gressive increase of maximal K-readings 
from 55.5 D to 57.4 D until May 2004, the 
date of X-linking treatment. After X-linking, 
maximal K-readings decreased to 56.4 D at 
20 months after treatment.
not recognized by the surgeon at that 
time (Fig. 1A). At the first postoperative 
day, vision was markedly decreased and 
the patient decided to postpone surgery 
of the fellow eye.
 In our initial examination in February 
2004, at 10 months after primary sur-
gery, the left eye showed a UCVA of 20/
400, a BSCVA of 20/60 and a corneal 
thickness of 610 µm. Slit lamp examina-
tion revealed a normal state after LASIK. 
Corneal topography showed decentered 
ablation with marked inferior steepen-
ing (maximal K readings of 55.5D) con-
sistent with the diagnosis of iatrogenic 
keratectasia after LASIK (Fig. 1B).
In the following 3 months we ob-
served distinct progression of keratecta-
sia in the left eye with a maximal K read-
ing of 57.4D in May 2004 (Fig. 1C). Since 
penetrating keratoplasty was the only 
valuable therapeutic alternative, we 
suggested UV/riboflavin-induced cross-
linking as a treatment option to the pa-
tient. Informed consent was obtained 
after the nature of the procedure and its 
known risks had been explained. During 
the 20 months following treatment cor-
neal topography of the left eye showed 
continuous regression of maximal K 
readings (Fig. 1D and Fig. 2). BSCVA at 20 
months after treatment was 20/25 with 
rigid contact lenses.
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Figure 3. Bilateral iatrogenic 
keratectasia after LASIK surgery. 
A: Right cornea with iatrogenic 
keratectasia at 12 months after 
LASIK surgery. B: Right cornea 
topographically unchanged at 19 
months after LASIK surgery. C: 
Left cornea at 12 months after 
LASIK surgery. D: Left cornea 
seven months after X-linking 
with distinct decrease of keratec-
tasia.
Case 2: 
Bilateral keratectasia after LASIK 
without apparent preoperative ectatic 
disorder 
Another patient showed bilateral ker-
atectasia (Fig. 3A,C) one year after LASIK 
surgery with slow progression observed 
in both eyes. X-linking was performed in 
the left, non-dominant eye. Preoperative 
central corneal thickness was 400 µm. At 
2 weeks after treatment, we noticed 
localized endothelial damage with con-
comitant stromal oedema in the central 
cornea. Stromal oedema slowly resolved 
within the following 6 weeks. At 7 
months after treatment, corneal topog-
raphy of the left eye showed a signifi-
cant decrease of central corneal steep-
ening (Fig. 3D) whereas in the right eye, 
corneal steepening remained un-
changed (Fig. 3B). At 9 months, the cen-
tral irregular endothelium had cleared 
and the endothelial cell count yielded 
2350 cells/mm2 with mild polymor-
phism.
Discussion
Although LASIK surgery has become 
increasingly safe and predictable in the 
last years, induced keratectasia remains 
a rare but devastating complication for 
which the underlying reasons are yet 
not fully understood. Therefore, it cer-
tainly is an advantage to have new 
therapeutic means to handle a compli-
cation of such severity after elective 
surgery. Clearly, prevention of induced 
keratectasia was the better strategy and 
special emphasis should be taken to 
recognize corneas at risk preoperatively. 
Reduction of corneal biomechanical 
strength seems to be an essential ele-
ment in the chain of events leading to 
induced keratectasia after LASIK. The 
anterior part of the corneal stroma con-
fers more biomechanical strength to the 
cornea than the posterior stroma 78 and 
it is the anterior stroma that is weakened 
by flap generation and tissue ablation in 
LASIK surgery. It would therefore be of 
great clinical value to have a tool to de-
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termine the individual biomechanical 
strength of a cornea preoperatively. 
Such a tool would enable us to detect 
corneas at risk preoperatively. Unfortu-
nately, such a technique is not yet avail-
able but there are promising approaches 
currently investigated such as determi-
nation of corneal hysteresis using an 
ocular response analyzer or interfero-
metric measurements. 79, 80
A possible future scenario would then 
be to either treat these corneas by ad-
vanced surface ablation, if applicable or 
perform a pre-treatment with X-linking, 
followed by LASIK surgery.
Our results show that riboflavin/UVA 
corneal cross-linking can at least slow 
down, arrest progressive, and even par-
tially reverse iatrogenic keratectasia 
after LASIK. The observed reduction of 
maximal K-values is due to the increased 
biomechanical stability of the cornea 
after cross-linking and is in line with 
similar findings in primary keratoconus 
patients treated similarly. 62 These pre-
liminary results demonstrate at least a 
middle-term efficacy of the technique. 
However, as with any new surgical tech-
nique, safety is a concern. With this 
technique, special emphasis should be 
taken preoperatively on minimal corneal 
thickness because of potential cytotoxic 
effects of UVA on corneal endothelial 
cells. 
Previous experimental studies in the 
rabbit cornea as well as in vitro studies 
in endothelial cell cultures on cytotoxic-
ity to the corneal endothelium have 
clearly shown that the cytotoxic effect 
starts at a local irradiance of 0.35 mW/
cm2. 59, 61 Assuming a stroma saturated 
with riboflavin and a surface irradiance 
of 3 mW/cm2, endothelial damage 
would occur at a depth of 320 µm and 
less. Therefore, we recommend a preop-
erative corneal thickness of at least 400 
µm to protect the corneal endothelium 
by the overlying stroma saturated with 
riboflavin (“riboflavin shielding”). After 
intraoperative removal of the epithe-
lium, minimal stromal thickness gets 
close to the 320 µm-limit leading to an 
increased risk for localized endothelial 
cell damage. In the previous clinical 
phase 1 study minimal corneal thickness 
was more than 400µm in all cases and 
no endothelial damage was observed. 62
In the second case presented here 
where localized endothelial damage 
after X-linking was observed, central 
corneal thickness was 400 µm including 
the epithelium. In such cases, it is rec-
ommended to increase corneal thick-
ness to 400 µm and more by swelling 
using saline solution. A similar scenario 
may occur if the UVA light source pro-
vides an average irradiance of 3 mW/
cm2, however, the irradiation field con-
tains “hot spots”. In such a case the dam-
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age threshold for endothelial cells may 
be exceeded locally and therefore, a UV 
light homogenous within the field of 
application is mandatory for safety of 
UVA/riboflavin cross-linking of the cor-
nea (Spoerl et al., submitted)
A major factor predisposing to LASIK-
induced keratectasia comprises unrec-
ognized thinning corneal disorders such 
as keratoconus (KC) or pellucid marginal 
corneal degeneration (PMCD) including 
formes frustes of both diseases. In both 
conditions, altered collagen orientation 
and structure lead to a decreased bio-
mechanical strength of the tissue. 81, 82 
Although all authors agree that corneal 
thinning disorders represent a contrain-
dication for LASIK and although various 
indices have been proposed for the rec-
ognition of ectatic disorders in corneal 
topography, 65, 83 the identification of 
formes frustes of KC or PMCD still re-
mains difficult in some cases. 
Other factors include re-treatments, 
thin corneas and low residual stromal 
thickness (RST), either due to generation 
of thick flaps or excessive tissue abla-
tion. 71, 72, 84-87 Here, some authors sug-
gest that an absolute RST of at least 250 
µm should be always respected whereas 
others suggest that the risk for ectasia 
occurs when the ablation reduces cor-
neal thickness to 55% or more of the 
preoperative values 55, 70, 86, 87 or even 
that the minimal corneal thickness 
might be specific to the individual eye. 71 
In some cases of iatrogenic keratectasia, 
however, even postoperatively, the rea-
son for the keratectasia remains unclear 
and we have to assume a decreased but 
asymptomatic biomechanical strength 
as described in case 2 of this study.
In conclusion, riboflavin/UVA corneal 
cross-linking increases the biomechani-
cal stability of the cornea and may thus 
be a therapeutic means to slow down or 
even arrest the progression of LASIK-
induced keratectasia. Further studies 
must include larger patient numbers 
and longer follow-ups to verify the per-
manency of the induced effects and 
safety and efficacy of X-linking.
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Part 3 
Prevention of 
Complications in Refractive 
Laser Surgery
64
3.1
Ablation Profiles in Corneal Laser Surgery.
Current and Future Concepts.
65
Abstract
Objective. The predictability and quality of results in corneal refractive laser surgery 
are determined by a number of factors. The calculation and choice of the ablation 
profile represent central elements. The growing knowledge about the physical and 
optical properties of the eye in recent years has led to the development of different 
strategies in the generation of ablation profiles. Here we describe the advantages 
and disadvantages of current ablation profiles and provides an outlook of future 
methods for the calculation of ablation profiles. Currently, differentation is taken 
between cornea-based ablation profiles and the entire human optics. With excep-
tion of „Ray tracing“, all ablation profiles share the use of theoretical eye models but 
with different assumptions and data measurement. These type of eye models are 
subject to continous development and improvement.
Conclusions. Whereas all other ablation profiles use standardized eye models to 
calculate the data, Ray tracing would enable the calculation of an ablation profile 
based on an individualized eye model. The latter created the use of wavefront analy-
sis, corneal topopgraphy and biometry from the individual patient. This strategy 
might in the future enable one achieve the perfect ablation profile.
Mrochen M, Hafezi F, Jankov M, Seiler T.
Ophthalmologe 2006; 103:175-183
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Ablation profiles 
based on the entire 
optics
„Classic“ ablation profile
The ablation profile based on the 
Munnerlyn formula represents the old-
est profile used in refractive laser sur-
gery (Fig. 1). It was introduced in 1988. 
Soon thereafter, the ablation profile was 
used in photorefractive keratectomy 
(PRK) and in laser in situ keratomileusis 
(LASIK), 88 which was solely based on the 
subjective refraction of the patient. Al-
though well-suited for sphero-cylin-
drical corrections, this ablation profile 
does not take into consideration the 
corneal asphericity. Thus, the ablation 
profile is rather suited for paraxiel space 
and small optical zones.
Wavefront-optimized ablation 
profile
Wavefront errors of high order in-
crease after refractive surgery. 14, 89-92 
Kohnen et al. investigated the optical 
ablation after LASIK for myopia and hy-
peropia. 93 This investigation showed the 
induction of primary positive spherical 
aberations in myopic corrections and 
the induction of primary negative sphe-
rical aberations in hyperoic corrections. 
Conclusively, there is an increase of asti-
gmatism of higher order (4th Zernike 
order). Each form has a significant influ-
ence on visual acuity. 94 Wavefront-
optimized ablation profiles have been 
introduced to compensate for this in-
crease. 95 The aim is to retain the physio-
logical state of the eye and not to 
change it by a refractive procedure. 
Some laser manufacturers have re-
placed the „classic,“ Munnerlyn formula 
based ablation profile by this optimized 
ablation profile. The main difference of 
action is in the periphery of the ablation 
zone where spherical aberration is af-
fected (Fig. 1). Wavefront optimized 
treatments do not require time consum-
ing aberrometry and interpretation of 
data, which are necessary for wavefront-
guided ablation profiles. The authors 
used the wavefront optimized treated 
ablation profile routinely on the non-
dominate eye.
Conclusively, induced spherical abera-
tions reduces the quality of the optical 
image. All other aberations that are not 
taken into consideration by this ablation 
profile are less relevant that spherical 
aberation alone. Therefore, the aim of 
wavefront optimized treatment is to 
maintain the preoperative state of the 
eye. 
In the correction of myopia, the ad-
vantages of this aberation profile have 
been shown clinically in a FDA con-
trolled trial. The refractive rate of suc-
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Figure 1.  Generation of a topography-guided ablation profile.
Figure 2. Difference between the „classic“ Munnerlyn and the wavefront-optimized ablation profile.
Figure 3. Generation of a wavefront-guided ablation profile.
cess, as defined by the percentage of 
operated eyes lying within an interval of 
±0.5D of target refraction, is over 80%. 
This rate is considered today’s standard. 
In more than 60% of the eyes operated, 
there is a post-operative increase in 
visual acuity of at least one Snellen line. 
In addition, a patient survey proved 
significant improvement in mesopic 
vision. 
Wavefront-guided ablation 
profile
Theo Seiler performed the first 
wavefront-guided treatment in 1999. 
Since then, this type of ablation profile 
has become the best practice model in 
primary treatments. 31, 96, 97 Similar to 
t o p o g r a p h y - g u i d e d t r e a t m e n t s , 
wavefront-guided profiles are custom-
ized according to the individual errors of 
the eye while the consideration of the 
errors of the entire optics. 
The currently used measurement sys-
tems are the Hartmann-Shack-Sensor 
and the Tscherning aberometer. In both 
systems, laser beams cross the optics 
and the resulting beam deviation is 
measured. In the case of the Hartmann-
Shack sensor, the light beam that had 
been scattered by the retina is trans-
ferred to a point matrix using a micro-
lens structure. In contrast, the Tschern-
ing aberrometer projects a point matrix 
onto the retina. The resulting matrix is 
recorded using a camera system. Next, 
the resulting individual wavefront is 
approximated using Zernike polynomi-
als, and the ablation profile is then di-
rectly calculated (Fig. 2). The generation 
of a wavefront-guided profile therefore 
also represents an approximation, how-
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ever, the high number of polynomials 
used leads to a high level of precision.
The wavefront-guided treatment has 
become the most frequently used abla-
tion profile and has been incorporated 
by all major excimer laser producers. 
Upon the introduction of this profile in 
1999, various authors stated that this 
profile might be able to increase UCVA 
(„eagle eye“) and almost reach the abso-
lute limit given by the interphotorecep-
tor distance of the retina. However, 
these high expectations were only 
reached in 5-20% of patients. Possible 
reasons include laser-tissue interactions, 
the individual corneal healing response, 
induced aberrations during generation 
of the flap and microdecentrations dur-
ing spherocylindrical ablation (i.e. zyclo-
rotation). 
Nevertheless the wavefront-guided 
profile shows one significant advantage 
over the formlery used „classic“ profile: 
the total aberrations of the eye either 
remained stable or reduced. Thus, the 
frequent complication of glare and halos 
under mesopic conditions, as observed 
in corrections using the „classic“ profile, 
were eliminated. 98 
A remaining critical issue is the pre-
operative predictability regarding which 
eyes will benefit from such a treatment. 
A number of studies show that eyes with 
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Figure 4. Decision-making process for the selection of ablation profiles.
a preoperative wavefront error of higher 
order of more than 0.3 µm (rmsh = root 
mean square of higher order aberra-
tions, OSA notations, pupil diameter 7 
mm) will profit from a wavefront-guided 
treatment. The optical aberrations 
strongly increase with the diameter of 
the human optics and are neglectable in 
optical (pupil) diameters of less than 4 
mm. Therefore, even the wavefront-
guided profiles use a „classic“ profile for 
the ablation of the central optics and 
only correct for spherocylindrical error., 
The peripheral zones are then treated 
using the individual wavefront data. 
Conclusively, the treatment of the cen-
tral cornea determines postoperative 
refraction and treatment of the corneal 
periphery increases the quality of post-
operative vision.
Ablation profiles 
based on the cornea
Topography-guided ablation 
profile
Multiple laser manufacturer have had 
varying success offering topography-
guided ablation profiles. 5, 29, 99 A differ-
ence height map is calculated on a cor-
nea topography (Fig. 3A), and the rela-
tive height data area is determined by 
using a reference asphere (Fig. 3B). This 
difference map is then approximated 
using polynomials that are used with 
the refractive data. This ablation profile 
adapts to the individual cornea curva-
ture and takes into account the wave-
front error of the anterior corneal sur-
face. This profile is sometimes called 
„cornea wavefront,“ which is a mislead-
ing term. The topography-guided profile 
is particularly useful in the reduction of 
major irregularities of the corneal ante-
rior surface, i.e. in cornea scars, irregular 
astigmatism following keratoplasties 
and cataract operations (Hafezi et al., 
personal communication), in decentered 
ablation, small optical zones or „central 
steep islands“ following refractive sur-
gery. This profile reduces massive irregu-
larities and aberrations. 
A topography-guided ablation profile 
can only be used in primary treatments 
since the reduction of cornea aberration 
might lead to an increase of the total 
aberrations of the optics. 100
Q Factor-adjusted ablation 
profile
The wavefront-guided treatment 
leads to a significant reduction of aber-
rations if the pre-operative total aberra-
tions were significant. This constellation 
is found in approximately 20% of cases. 
In all other cases, the aim is rather to 
preserve the physiological state of op-
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Figure 5.  Overview of past, current and future ablation profiles.
tics in the most optimal way. Cornea 
asphericity determines the quality of the 
image, whereas the corneal curvature 
determines refractive changes. This as-
phercity represents the aim of the Q 
factor-adjusted ablation profile - preser-
vation of the pre-operated asphericity 
and the ability of inducing specific aber-
ration for the treatment of astigmatism 
and presbyopia. 
The Q factor is the determinant of 
corneal asphericity, which lies between 
-0.8 and 0.4 in the normal population 
with a peak of -0.2. 101 Therefore, the 
human cornea physiologically shows a 
slightly prolate form - it flattens from the 
center to the preiphery. It has been 
shown repeatedly that refractive laser 
surgery for the correction of myopia 
shifts corneal asphercity to an oblate 
cornea. Several scientific groups have 
calculated the ideal postoperative cor-
neal asphercity to be -0.4. 102, 103
In a recent study, Koller et al. com-
pared Q factor-adjusted and wavefront 
guided treatements in paired eyes. 10 
They found no significant or clinically 
relevant differences regarding the re-
fractive and the visual results. Only, 
„coma-like“ aberrations were better 
treated using wavefront guided profiles.
Another aspect of corneal asphercity 
is correction of astigmatism. Aspherictiy 
is not equal in all meridians and can 
enhance or weaken corneal astigma-
tism. Therefore, correction of the central 
astigmatism is not sufficient for achiev-
eing an ideal aspheric corneal form since 
meridian differences of asphericity need 
to be taken into consideration. 
Future ablation 
profiles
“Ray tracing”
Ray tracing profile considers not only 
corneal topographic data but also aber-
rometry and biometry. Ray tracing is 
defined as the tracing and calculation of 
light rays through an optical system. The 
unique feature of Ray tracing is that in 
contrast with all aberration profiles used, 
Ray tracing does not rely on a „general“ 
eye model as the basis of the calculation 
of the aberration profile. It rather uses 
an individualized eye model based on 
the biometric and topographic data of 
the particular patient. This model should 
help achieve a precise refractive result to 
enhance the quality of the retinal image 
for all pupil diameters (Fig. 5F).
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Discussion
Refractive laser surgery of the cornea 
has seen great advances in the past 
years. On one hand, technological ad-
vances like the continous improvement 
of the laser systems from the „scanning 
slit“ to modern „flying spot lasers“ have 
been made. On the other hand, ablation 
profiles have been continously im-
proved. Figure 4 shows a decision tree 
that should help the refractive surgeon 
to use the best suited ablation profile. 
The wavefront-optimized profile, which 
has been derived from the „classic“ pro-
file (Fig. 5A), precompensates for the 
spherical aberration induced by the 
refractive procedure itself (Fig. 5B). The 
variance of refractive results is low for 
minor corrections but rises with the 
height of myopia. 
In other words; the wavefront opti-
mized profile shows good results for 
minor myopic corrections but can lead 
to unprecise results in myopic correc-
tions for more than -7D. With these find-
ings, further ablation profiles were es-
tablished like the wavefront-guided 
profile (Fig. 5C) and the Q factor-
adjusted profile (Fig. 5D). 
Latest results indicate that patients 
with a rmsh-OSA value of more than 
0.3µm (7.0mm pupil) show a lesser 
postoperative variance when a wave-
front guided-profile is used (G. Kezirian, 
personal communication). In patients 
with a rmsh-OSA of less than 0.3µm a 
combination of wavefront optimized or 
Q factor-adjusted profile is sufficient (T. 
Seiler, personal communication). In 
cases where a wavefront analysis is not 
possible for technical reasons (vitreous 
opacities, reflections of an intraocular 
lens, high corneal aberrations) or in 
cases with a highly irregular cornea, a 
topographically-guided profile (Fig. 5E) 
should be used. 
The Ray tracing method could be an 
alternative in the future (Fig. 5F). Where-
as all other ablation profiles use stan-
dardized eye models to calculate the 
data, Ray tracing would enable the cal-
culation of an ablation profile based on 
an individualized eye model. The latter 
created the use of wavefront analysis, 
corneal topopgraphy and biometry from 
the individual patient. This strategy 
might enable one achieve the perfect 
ablation profile. 
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3.2
Transferring Wavefront Measurements into Corneal 
Ablations: an Overview of Related Topics
75
Abstract
Objective. We give an overview of possible side effects that are specific for, or of 
particular relevance in, customized treatments. Certain processes involved in cus-
tomized ablations have the potential to alter the quality of the optical correction. 
Professionals associated with customized treatment should be informed and trained 
with respect to possible sources of error.
Conclusions. The use of wavefront aberrations and corneal topography as a basis 
for customized ablations is a complex matter. A perfect wavefront measurement 
does not necessarily guarantee a perfect result after treatment. Other factors related 
to the technology and the clinical status of the patient must be considered for pre-
dicting the outcomes of a customized ablation. Besides this, the chain of processes 
involved in customized surgery requires not only well-trained surgeons; all profes-
sionals involved in the diagnosis and treatment should be informed and trained with 
respect to possible sources of error of customized ablations.
Mrochen M, Bueeler M, Iseli HP, Hafezi F, Seiler T.
J Refract Surg 2004; 20:S550-S554
3.2 Wavefront measurements
76
Introduction
The aim of this report is to give an 
overview of side effects and possible 
sources of error that might affect pre-
dictability, efficacy, or safety when trans-
ferring a theoretical ablation profile onto 
a vital cornea. To demonstrate the com-
plexity of this issue, we are focusing on 
side effects directly linked to the tech-
nology used for pre- and intraoperative 
diagnostics and treatment (Fig. 1). Our 
intention with this report is to sensitize 
clinicians and other professionals to the 
impact of side effects on optical out-
comes.
The eye needs 
standardization
The influences of a patient’s eye con-
dition during corneal topography or 
wavefront sensing have been studied in 
detail and reported frequently in the 
literature. Reasons are manifold and 
range from tear film conditions to pa-
tients’ ability to fixate, status of accom-
modation, or head tilts that are usually 
difficult to control. A problem of clinical 
relevance is the influence of the tear film 
during wavefront sensing. Usually, single 
spots are not well detected in Shack- 
Hartmann or Tscherning images and, 
thus, the wavefront is plagued with a 
larger error. The question is: Should the 
investigator apply artificial tears to 
achieve a more precise detection of 
spots with the risk of altering the indi-
vidual wavefront by the introduction of 
this additional factor? This specific ex-
ample might show the importance of 
standard procedures in clinical routine. 
Further clinical research should focus on 
such standards for wavefront sensing 
and corneal topography. One should 
keep in mind that optical aberrations are 
not stable and vary over time and age. 
104, 105 In addition, fluctuations of optical 
aberrations with accommodation or the 
pulse heart rate have been shown. 106 
Consequently, standards for wavefront 
sensing should address such factors.
Fixation during 
measurement and 
treatment
The report of optical errors such as 
wavefront aberrations with respect to 
the line of sight is accepted in ophthal-
mology. However, to determine the line 
of sight, precise measurements of the 
pupil location are not the only prerequi-
site. Centration also requires the pa-
tient’s ability to fixate on a fixation light 
that is coaxially aligned to the optical 
axis of the measuring device. Creating a 
flap or removing the epithelium during 
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treatment reduces the image quality of 
the fixation light. Thus, the patient may 
lose the capability of accurate fixation. 
Similarly, precision of detection of the 
entrance pupil is reduced due to light 
scattered by a rough cornea. Generally, 
centration is a task of 6 degrees of free-
dom. The eye is able to perform horizon-
tal and vertical shifts; it is able to rotate 
around its longitudinal, horizontal, and 
vertical axes; and it can move back and 
forth. Most commercially available eye-
tracking systems measure and compen-
sate lateral eye movements along the 
horizontal and vertical axis of the eye 
and some eye-tracking systems are ca-
pable of compensating for rotations 
around the longitudinal axis (cyclotor-
sion). Nevertheless, all eye-tracking de-
vices (centration and registration) need 
the cooperation of the patient. Eye-
tracking systems are built to compen-
sate for eye movement and to center the 
measurement and the treatment with 
respect to the line of sight. Besides the 
benefits, the use of an eye-tracking sys-
tem bares the risk of new possible 
sources of error such as inaccurate cali-
bration between the detection of the 
eye’s position (e.g., video camera) and 
the optical path of the laser beam 
(scanning mirrors). Such an error may 
result in under- or overcorrection, sys-
tematic decentrations, or large spherical 
aberrations.
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Figure 1. Overview of the processes involved in customized ablation. Each process has specific sources of error 
that may affect the outcome of a refractive procedure.
Wavefront sensing 
and 
corneal topography
Calibration errors or misalignment of 
the optical scheme are a source of error 
because the user might not be able to 
determine such errors before each 
measurement. Wavefront and topogra-
phy data that are used for a customized 
treatment should be used only after 
verification of the system calibration. 
Whereas in optical diagnosis such errors 
might not play a significant role, they 
may have a substantial impact when 
treatments are based on data measured 
incorrectly. We should keep in mind that 
an ablation of only 10 μm can cause a 
change of several diopters when the 
treatment is performed within a small 
zone. Manufacturers provide test eyes 
and certain verification methods for the 
calibration of their devices to avoid such 
calibration errors. Those tests are often 
time consuming but they should be 
performed before measurements for 
customized treatment are initiated.
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Figure 2. The principle of transferring a wavefront map into an ablation profile. Inversion of the wavefront map, 
conversion into geometrical shape information and offset for the ablation profile.
Wavefront reconstruct 
algorithms
In principle, wavefront sensors deter-
mine the first derivative of the wave-
front (slope) at a specific point within 
the pupil. One gets a set of measured 
wavefront slopes distributed over the 
entire pupil. Wavefront reconstruction 
methods fit the slope data to a set of 
polynomials with a least square tech-
nique. Typically, the polynomial set for 
wavefront fitting has been either Zer-
nike or Taylor polynomials. The least 
square techniques minimize the abso-
lute error between the measured slopes 
and the reconstructed wavefront. From 
the principles of fitting, there is a resid-
ual error between the reconstructed 
wavefront and the measured slopes. 107 
The amount of residual error depends 
on the number of sample points and the 
number of polynomials used for fitting. 
As a rule of thumb, the number of sam-
pling points should be three times more 
than the number of polynomials. Espe-
cially in highly aberrated eyes, the fitting 
errors can cause a significant under- or 
overestimation of wavefront aberrations 
and may lead to poor outcomes when 
used for ablation profile calculations. 
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Figure 3. Ablated profiles after simulated scanning spot correction of vertical coma. Each row corresponds to a 
different combination of spot size D and central ablation depth per pulse dc. The first column shows the ideal 
ablation profile. The following columns depict the approximations of the same profile resulting from scanning spot 
laser ablation performed with increasing eye tracker latency.
Ablation profile 
calculation
The design of ablation profiles is usu-
ally based on theoretical eye models 
that should represent the optical behav-
iour of the human eye. The simplest way 
is to use the refractive power and shape 
of the anterior front surface of the cor-
nea as a basis to calculate the required 
tissue removal for a spherocylindrical 
correction within a given optical zone. 
This general assumption, originally 
made by Munnerlyn 88, was used to de-
termine the amount of tissue that must 
be removed from a spherical cornea to 
achieve a postoperative spherical cor-
nea with a different radius of curvature 
by simple geometrical considerations. 
This derivation assumed both the thin 
lens theory and paraxial optics. Later, 
various authors improved the assump-
tions for pre- and postoperative corneal 
shape by the introduction of corneal 
asphericity or methods for precompen-
sating specific higher-order aberrations. 
Three general steps can achieve an 
ablation profile from a wavefront meas-
urement: 
1) Inversion of the wavefront map: As 
the aim is to correct the wavefront, one 
must reverse signs/orientation of the 
wavefront. If two or more wavefront 
aberrations are calculated in the same 
reference plane, they can be added or 
subtracted. 
2) Conversion of the wavefront map: 
The wavefront information must be 
transferred into corresponding geomet-
rical shape information. In a first ap-
proximation, this can be done by simply 
assuming the wavefront is equal to the 
optical path difference in the eye, which 
usually is correct for small aberrations 
observed in normal eyes. As the optical 
path difference is the product of geo-
metrical length times the refractive in-
dex, one could easily derive the ablation 
profile in terms of a height map. 
3) Offset for the ablation profile: As 
refractive surgery lasers are only able to 
remove tissue, one must consider this 
fact in ablation profile design. The geo-
metrical information derived from the 
wavefront must be shifted by the ampli-
tude of the height profile. 
Figure 2 gives an example for this 
transfer of the ablation profile. An initial 
wavefront with peak-to-peak values of 
only 4 μm results in an ablation profile 
with a maximal ablation depth of ap-
proximately 12 μm. Generally, ablation 
profile design requires an eye model 
including optical and geometrical as-
sumptions of the individual eye. Includ-
ing more measured data into such a 
model will improve the eye model in 
predicting the optical situation of an 
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individual eye. In contrast, including 
more measured data for the individual 
ablation profile calculations also bares 
the risk of introducing more sources of 
error in the calculation process. We 
should remember that all measure-
ments are plagued with a certain error 
and, if measurements are combined, the 
errors are usually increased-law of error 
propagation.
Spot size, single spot 
ablation depth and 
eye-tracking latency
Only limited data on the theoretical 
impact of intraoperative eye movements 
on the optical outcome of refractive 
treatments with a scanning spot laser 
are published. 108 In scanning spot laser 
surgery, the ideal corneal surface is ap-
proximated by directing and overlap-
ping a finite number of laser pulses. 
Displacements of single laser shots from 
their ideal overlap positions may have 
the potential to significantly decrease 
the accuracy of the desired correction 
and to increase the surface roughness 
after ablation. When the eye does not 
move, a small spot is able to correct finer 
details (higher Zernike modes) than a 
larger spot. 109 
This situation changes when posi-
tioning errors of the single laser spots 
due to incomplete compensation of eye 
movements are introduced (Fig. 3). In 
this more realistic case, a reduction of 
the spot diameter reduces the stability 
of the correction toward spot displace-
ments. So far, combinations of a large 
spot diameter (typically 0.75 to 1.00 
mm) and a small ablation depth per 
pulse (typically 0.2 to 0.3 μm) yield the 
best parameters in case of typical eye-
tracking latencies (1 ms). 108
Radiant exposure 
(fluence)
Changes in the ablation depth for 
each single laser pulse, when moving 
the laser beam from the corneal apex 
toward the limbus, changes the angle of 
light incidence resulting in significant 
undercorrection in the periphery and 
consequently generation of spherical 
aberrations are known. 110 Energy drifts 
or fluctuations during a treatment may 
further influence the optical outcome. 
Even more important is the stability of 
the laser ablation. If the radiant expo-
sure is reduced and reaches values in 
the order of the ablation threshold, one 
receives unpredictable ablation depths. 
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The ablation process gets more sensi-
tive regarding environmental conditions 
such as temperature, individual varia-
tions in the ablation rates, humidity, 
alcohol concentration in the air, or air-
flow. For example, after the epithelium is 
removed or the flap is opened, the cor-
nea starts to dehydrate. Decreasing the 
water content results in higher ablation 
efficiency for the collagen structure and, 
thus, in a higher amount of effective 
ablation depth after the cornea has 
been rehydrated. 36 Furthermore, a thin 
water film might shield the laser radia-
tion after the corneal wound bed is 
cleaned with a liquid before ablation. 
Even water has been assumed to have a 
small absorption coefficient at 193 nm 
radiation under physiological condi-
tions; absorption increases by several 
orders of magnitude during the photo-
ablation process. 111 
An increase in radiant exposure leads 
to a more stable and reliable ablation 
per pulse; however, increasing the radi-
ant exposure will also increase the am-
plitudes of the acoustic waves that are 
induced during the ablation process. 112 
Those high stress waves may harm the 
corneal endothelium or other fragile 
structures in the eye. 
Consequently, the range of radiant 
exposures that can be used in clinical 
routine is limited to a range of approxi-
mately 150 to 600 mJ/cm2 dependent 
on the type of beam profile used-
Gaussian or top hat.
Postoperative 
variability in wound 
healing
The influence of the individual vari-
ability in wound healing on optical out-
comes in terms of wavefront aberrations 
is thus far unknown. Future clinical trials 
should provide data on biomechanical 
effects, epithelium remodelling, and 
stromal wound healing in terms of pre-
dictability of individual results. Based on 
such data, one may be able to simulate 
the expected outcome for a specific eye 
and to include such factors in the abla-
tion profile design. 
Conclusion
In summary, the use of wavefront 
aberrations and corneal topography as a 
basis for customized ablations is a com-
plex matter. A perfect wavefront meas-
urement does not necessarily guarantee 
a perfect result after treatment. Other 
factors related to the technology and 
the clinical status of the patient must be 
considered for predicting the outcomes 
of a customized ablation. Besides this, 
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the chain of processes involved in cus-
tomized surgery requires not only well-
trained surgeons; all professionals in-
volved in the diagnosis and treatment 
should be informed and trained with 
respect to possible sources of error of 
customized ablations.
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3.3
Q-factor Customized Ablation Profile
for the Correction of Myopic Astigmatism
3.3 Q-factor profile
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Abstract
Objective. To compare the results of the Q-factor customized aspheric ablation pro-
file with the wavefront-guided customized ablation pattern for the correction of 
myopic astigmatism.
Methods. Thirty-five patients were enrolled in a controlled study in which the non-
dominant eye was treated with the Q-factor customized profile (custom-Q study 
group) and the dominant eye was treated with wavefront-guided customized abla-
tion (control group). Preoperative and 1-month postoperative high-contrast visual 
acuity, low-contrast visual acuity, and glare visual acuity, as well as aberrometry and 
asphericity of the cornea, were compared between the 2 groups. All eyes received 
laser in situ keratomileusis surgery, and the laser treatment was accomplished with 
the Wavelight Eye-Q 400 Hz excimer laser.
Results. For corrections up to -9 diopters (D) of myopia, there were no statistically 
significant differences between the 2 groups regarding any visual or optical parame-
ter except coma-like aberrations (3rd Zernike order), where the wavefront-guided 
group was significantly better 1 month after surgery (P = 0.002). For corrections up to 
-5 D (spherical equivalent), the Q-factor optimized treated eyes had a significantly 
smaller shift toward oblate cornea: ∆Q15 = 0.25 in Q-factor customized versus ∆Q15 = 
0.38 in wavefront-guided treatment (P = 0.04).
Conclusions. Regarding safety and refractive efficacy, custom-Q ablation profiles 
were clinically equivalent to wavefront-guided profiles in corrections of myopia up 
to -9 D and astigmatism up to 2.5 D. Corneal asphericity was less impaired by the 
custom-Q treatment up to -5 D of myopia.
Koller T, Iseli HP, Hafezi F, Mrochen M, Seiler T.
J Cataract Refract Surg 2006; 32(4):584-589
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Introduction
Corneal refractive surgery is based on 
the change in corneal curvature to com-
pensate for refractive errors of the eye. 
After many mechanical approaches, 
such as radial keratotomy, keratomile-
usis, and astigmatic keratotomies, abla-
tive procedures using the excimer laser 
have become the most successful tech-
nique. It was mainly the submicron pre-
cision and the high repeatability of the 
ablation of the cornea accompanied by 
minimal side effects that guaranteed 
this success. 
Standard ablation profiles for the cor-
rection of myopic astigmatism were 
based on the removal of convex–con-
cave tissue lenticules with spherocylin-
drical surfaces. 88 Although these algo-
rithms proved to be effective to com-
pensate for refractive error, the quality 
of vision deteriorated significantly, es-
pecially under mesopic and low-contrast 
conditions. 89, 113-115 As a logical conse-
quence, research was directed toward 
aspheric ablation profiles, wavefront 
analysis of the eyes operated on, and the 
optical aberrations induced by the op-
erations. 14, 116, 117 
The results of a preoperative wave-
front analysis were used to create indi-
vidualized ablation patterns to also 
compensate for pre-existing aberrations 
102, 118; however, this analysis is time 
consuming and appears not to be nec-
essary in the majority of the cases. 
T h e r e f o r e , n e w a s p h e r i c n o n -
individualized algorithms were designed 
to compensate for the spherical aberra-
tion induced, 95 which led to an im-
proved visual outcome. 119 On the other 
hand, it has been known for many years 
that any refractive treatment of the cor-
nea must respect the preoperative and 
postoperative asphericity of the cornea. 
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120-122 The outer surface of the human 
cornea is physiologically not spherical 
but rather like a conoid. 123 On average, 
the central part of the cornea has a 
stronger curvature than the periphery 
or, in other words, the refractive power 
of the outer corneal surface decreases 
from central toward peripheral. For this 
form, the term prolate cornea has been 
coined, and the opposite form is called 
oblate cornea. 
The physiologic asphericity of the 
cornea shows a significant individual 
variation ranging from mild oblate to 
moderate prolate. 123 Therefore, it was 
necessary to introduce a shape factor to 
characterize the amount of asphericity 
of the cornea numerically, the so-called 
Q-factor. Gatinel et al. 124 and Manns et 
al. 125 emphasized that the preoperative 
and postoperative Q-factors have sig-
nificant influence on the ablation depth 
and profile to be used, and Manns et al. 
125 concluded that a minimum of spheri-
cal aberration would be obtained at a 
target Q-factor of approximately -0.4. 
These calculations were based on an 
3.3 Q-factor profile
88
Figure 1. Ablation pattern for an attempted change in asphericity of 
∆Q = -0.6. In the central part, the ablation depth is virtually constant 
and resembles a phototherapeutic keratectomy. Toward the periph-
ery, a flattening produces the prolate cornea. The central ablation 
depth is 28.5 µm.
aspheric eye model, and the approxi-
mate target value of -0.4 to -0.5 holds for 
the whole range of myopic corrections 
up to -10 diopters (D).
In this study, we present refractive, 
optical, and visual results of an aspheric 
ablation algorithm that takes the preop-
erative and attempted postoperative Q-
factor of the cornea to be operated on 
into account. The nondominant eye of 
patients with myopic astigmatism was 
corrected using this algorithm, and the 
outcome at 1 month was compared with 
that in the dominant fellow eye that was 
treated by wavefront-guided ablation. 
Our interest was focused on the quality 
of vision and the induced wavefront 
aberrations.
Patients and methods
Study Group
Thirty-five patients seeking laser cor-
rection at the Institute for Refractive and 
Ophthalmic Surgery (IROC) were en-
rolled in this study. The age of the pa-
tients ranged from 23 to 53 years (mean 
35.37 years ± 8.64 [SD]). The refractive 
3.3 Q-factor profile
89
and demographic data are listed in Table 
1. All patients had LASIK in both eyes, 
the nondominant eye (study group) 
being operated on first and the domi-
nant eye (control group) 1 day later. On 
average, best spectacle-corrected visual 
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Figure 3. Increase in asphericity ∆Q = Qpost – Qpre in the wavefront-guided (rectangles) and the Q factor-
customized (circles) treated eyes in myopic corrections of -5 D and less. A positive value of ∆Q indicates a shift 
toward an oblate cornea. The bars depict the standard deviation. The difference between the groups is statistically 
significant for radial distances 10 degrees and 15 degrees from the apex (*).
Figure 2. Preoperative asphericity Q as a function of the radial distance from the apex of the cornea. A radial 
distance of 30 degrees is equivalent to an optical zone diameter of approximately 7.5 mm.
acuity (BSCVA) was significantly better in 
the dominant eye (1.127 ± 0.182 versus 
1.040 ± 0.247, P = 0.049). The target re-
fraction was emmetropia in 59 eyes and 
slight myopia between -0.50 D and -1.25 
D in 11 eyes because of intended mono-
vision. After a complete ophthalmic 
examination and a thorough discussion 
of the risks and benefits of the surgery, 
the patients gave written informed con-
sent. Exclusion criteria were any pathol-
ogy of the eyes, age under 20 years, 
asymmetric astigmatism detected in 
corneal topography, central corneal 
thickness less than 500 µm and residual 
stromal thickness of less than 270 µm, 
and high-order wavefront error (rmsh) of 
more than 0.35 µm in the nondominant 
eye (pupil size 7 mm). The study proto-
col was approved by the review board of 
the IROC.
Examinations
The complete preoperative ophthal-
mic examination consisted of autore-
fractometry and autokeratometry 
(Humphrey Model 599, Zeiss), corneal 
topography (Keratograph C, Oculus, 
equipped with Topolyzer software, 
Wavelight), manifest refraction using the 
fogging technique, uncorrected visual 
acuity (UCVA) and BSCVA, glare visual 
acuity and low-contrast visual acuity 
(Humphrey Model 599), wavefront 
analysis with pupils dilated to at least 7 
mm in diameter (Wavefront Analyzer, 
Wavelight), applanation tonometry, 
central ultrasound pachymetry (SP-2000, 
Tomey), and slitlamp inspection of the 
anterior and posterior segments of the 
eyes. All root-mean-square (RMS) values 
are reported at a pupil size of 7 mm. The 
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determinable glare visual acuity and 
low-contrast acuity values range on a 
decimal scale from 0 to 0.8 (equivalent 
to 20/25), whereas for UCVA and BSCVA, 
the maximum was 2.0 (equivalent to 20/
10). 
The patients were seen on postopera-
tive days 1 and 3 (if necessary) and 1 
month after surgery. On postoperative 
days 1 and 3, UCVA was measured and a 
slitlamp inspection was performed. At 
the 1-month follow-up, the examination 
was identical to preoperatively.
Q-Factor Analysis and 
Asphericity Treatment
Preoperative and postoperative Q-
factor analysis was performed by means 
of the corneal topographer. Only auto-
matically taken topographies were ac-
cepted. The Q-factor was calculated by 
the topography software in all 4 main 
hemimeridians at radial distances 10, 15, 
20, 25, and 30 degrees from the apex of 
the cornea, and for treatment, the aver-
age of 2 opposite hemimeridians was 
used as the Q-factor in the main axes. 
The preoperative and postoperative Q-
factors for numeric evaluation are the 
averages of all 4 hemimeridians. Since 
the aim was a postoperative prolate 
cornea, the target Q-factor was -0.4 
within a diameter of 6.5 mm in all cases. 
A typical ablation pattern attempting an 
asphericity change of ∆Q = -0.6 within 
an optical zone of 6.5 mm in diameter is 
shown in Figure 1.
Surgical Technique
All operations were performed as 
LASIK procedures. The microkeratome 
used was the M2 (Moria), with appropri-
ate suction rings selected according to 
the specifications of the manufacturer. 
The laser treatment was performed by 
means of the Eye-Q excimer laser with 
the custom-Q software (Wavelight). This 
device works at a repetition rate of 400 
Hz and produces a spot size of 0.68 mm 
(Full Width at Half Maximum, FWHM) 
with a truncated Gaussian energy pro-
file. Eye tracking is accomplished with a 
latency of 6 ms. The optical zone of full 
treatment had a diameter of 6.5 mm 
with a transition zone of 1.25 mm in 
both groups. After the flap was reposi-
tioned, the patient was given a bandage 
lens that was soaked with preservative-
free ofloxacin 0.3% (Floxal SDU) eye 
drops for 20 minutes. The bandage lens 
was removed the next morning. The 
surgery in the fellow eye was done on 2 
consecutive days. The postoperative 
medication consisted of fluorometholon 
0.1% (FML) twice a day for 1 week and 
artificial tears (Hylo-Comod) at the pa-
tient’s discretion.
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Statistical Analysis
Preoperative and postoperative pa-
rameters in the 2 groups as well as the 
preoperative versus postoperative 
changes (paired differences in each 
group were compared using the paired 
2-sided t test. A P value less than 0.05 
was considered statistically significant.
The vector analysis of astigmatism 
correction consisted of the calculation of 
the change in refractive cylinder in the 
preoperative axis, 126 and its percentage 
of the preoperative refractive astigma-
tism served as a measure for the effi-
ciency of astigmatism correction. Simi-
larly, to take the attempted undercorrec-
tion in some eyes of the custom Q-
group into account, the spherical correc-
tion efficiency was calculated as the 
percentage of the preoperative versus 
postoperative change in spherical 
equivalent compared to the target 
change in spherical equivalent.
Results
The surgery was uneventful in all 
cases. At postoperative day 1, 2 eyes 
showed a minor diffuse lamellar keratitis 
that resolved within 3 days using FML 
drops 4 times a day. At the 1-month 
examination, all eyes showed a regular 
state after LASIK. 
The refractive and visual data at the 1-
month follow-up are listed in Table 2. 
Twenty-eight eyes in the custom-group 
(80%) and 30 eyes in the wavefront-
guided group (86%) were within ±0.5 D 
of the target refraction. The preoperative 
statistically significant difference in 
BSCVA, better in the dominant eye, re-
mained significant 1 month after sur-
gery (P = 0.031). Regarding safety, both 
groups showed an identical distribution 
of lost versus gained lines of BSCVA (Ta-
ble 3). The eyes that lost 2 lines (1 in 
each group) belonged to 1 patient suf-
fering from severely dry eyes. 
Low-contrast visual acuity and glare 
visual acuity were preoperatively and 
postoperatively not statistically different 
in the 2 groups (Table 2). Also, the pre-
operative versus postoperative changes 
did not demonstrate statistical signifi-
cance in glare acuity (P = 0.724) or low-
contrast acuity (P = 0.418).
Regarding the asphericity of the cor-
nea, all eyes demonstrated a tendency 
toward an oblate cornea after surgery 
(Table 2). The preoperative Q-factor as a 
function of the radial distance from the 
apex is shown in Figure 2. The increase 
in asphericity ∆Q = Qpost - Qpre was ap-
proximately 4% higher for the custom-Q 
group. For all radial distances, the differ-
ence in ∆Q between the groups was not 
statistically significant. For corrections of 
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-5 D (spherical equivalent) and less, 
however, the results were different (Fig. 
3), showing a significantly smaller shift 
toward oblate in the Q-factor custom-
ized group. 
The total rmsh was preoperatively 
nearly identical in the 2 groups (0.242 ± 
0.086 µm and 0.237 ± 0.070 µm, Table 1) 
and remained postoperatively similar in 
both groups (0.442 ± 0.142 µm in the 
custom-Q and 0.381 ± 0.146 µm in the 
wavefront-guided group [P = 0.113]). 
The only statistically significant differ-
ence regarding wavefront errors was 
obtained in the postoperative coma-like 
aberrations S3 (RMS sum of 3rd-order 
aberrations) with 0.296 ± 0.115 µm in 
the custom-Q group versus 0.192 ± 
0.088 µm in the wavefront-guided 
group (P = 0.002). Another important 
detail is the similar induced spherical 
aberration (postoperative minus preop-
erative) in the 2 groups: 0.287 ± 0.219 
µm versus 0.295 ± 0.264 µm (P = 0.457).
Discussion
Wavefront-guided customized abla-
tion appears to be the gold standard for 
ablative treatment of myopic astigma-
tism regarding the optical performance 
of the postoperative eye. 127, 128 There-
fore, it was logical to compare a new 
algorithm such as the custom-Q profile 
with this standard. To exclude individual 
abnormal healing responses, we com-
pared fellow eyes with the dominant eye 
treated with wavefront-guided ablation 
and the nondominant eye treated with 
Q-factor customized. The choice to treat 
the dominant eyes with wavefront-
guided ablation was mainly based on 
ethical considerations because of the 
superiority of wavefront-guided algo-
rithms presumed before the study. Re-
garding refractive and visual outcomes 
in the study, however, we could not find 
any relevant differences (Tables 2 and 3) 
and conclude that the 2 treatment 
strategies appear to be clinically equiva-
lent. 
An important result is the only minor 
decrease in low-contrast visual acuity in 
both groups, which is remarkable be-
cause after conventional photorefractive 
keratectomy and LASIK, low-contrast 
visual acuity shows a significant reduc-
tion. 114, 129 Although not statistically 
significant, the better spherical success 
index (Table 2) in the wavefront-guided 
group means that the nomogram for 
spherical custom-Q treatments has to be 
improved, whereas the efficiency re-
garding astigmatic treatments was 
nearly equal in both groups. The small 
differences reported in this study might 
have become statistically significant if 
the group size would have been in-
creased; however, a group of 35 
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matched pairs is sufficient to detect a 
clinically meaningful result. 
Although the preoperative and post-
operative overall optical performance of 
the eyes treated by the 2 different pro-
files was very similar in the 2 groups, we 
found a statistically significant differ-
ence regarding the outcome of coma-
like 3rd-order aberrations S3. Whereas 
preoperative versus postoperative S3 
increased in the Q-factor customized 
group from 0.181 ± 0.072 µm preopera-
tively to 0.296 ± 0.115 µm postopera-
tively, S3 remained virtually constant in 
the wavefront-guided group, with 0.182 
± 0.094 µm preoperatively versus 0.192 
± 0.088 µm postoperatively.
This result is not surprising because 
the Q-factor customized approach does 
not correct coma-like aberrations. On 
the other hand, the increase in the total 
wavefront error due to the operation by 
a factor of 1.83 in the custom-Q group 
and 1.67 in the wavefront-guided group 
compares favourably with the increased 
factors with standard ablation profiles 
reported in the literature, which range 
from 1.92 130 to 17. 14 Such an increase in 
wavefront error during myopia correc-
tion is usually due to the inevitably in-
duced spherical aberration, which was 
identically small in the 2 groups. 
Chaalita et al. measured higher order 
aberrations and correlated them with 
subjective complaints of patients after 
LASIK surgery. 13 Whereas the total rmsh 
and spherical aberration were good 
quantitative descriptors for starburst 
and glare, coma was significantly related 
to double vision. In this study, the post-
operative glare visual acuity was on 
average better compared with the pre-
operative in both groups, which is con-
sistent with the relatively small increase 
in spherical aberration and total wave-
front error. 
So, if the optical performance of the 
eyes treated by the 2 alternative ap-
proaches is similar but coma-like aberra-
tions do better using wavefront-guided 
ablation, why should the wavefront-
guided approach not be preferred in any 
case? Wavefront-guided ablation re-
quires a time-consuming preoperative 
wavefront analysis including dilation of 
the pupil. In a high-volume refractive 
surgery practice, there is often little time 
to do such an intensive examination in 
any case. Not to speak of refractive sur-
gery in third world-countries where for 
economic reasons such time-consuming 
analysis is not well accepted. These and 
other aspects decrease the market 
penetration of wavefront-guided abla-
tion and create the demand for alterna-
tive customized ablation profiles.
We would have expected to find a 
significant difference in postoperative 
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Q-factors between the groups since we 
aimed on a postoperative Q-factor of 
-0.4 in the custom- Q group. Both goals 
were clearly missed, at least in higher 
corrections, because there was an un-
derlying strong shift toward an oblate 
cornea due to the myopic correction 
that is linearly related with the amount 
of myopia correction. 130 Thus, on aver-
age, a 4% greater shift toward oblate in 
the custom-Q group is well explained by 
the 3% higher myopia correction in this 
group compared with the wavefront- 
guided group (Table 2). A combination 
of 2 reasons have recently been consid-
ered to be responsible for this shift to-
ward oblate corneal shape 131: a periph-
eral undercorrection due to a reduced 
laser efficacy 110 and the structural re-
sponse of the cornea that is biome-
chanically weakened by the LASIK op-
eration itself. 132 Both ablation profiles 
used in this study include a so-called 
correction matrix that compensates for 
the reduced laser ablation in the periph-
eral cornea. 95 Therefore, we believe that 
in our cases, the shift was mainly due to 
a biological response of the cornea. 
A totally different picture is drawn 
when considering myopic corrections of 
-5 D and less. The corneas of the Q-
factor optimized treated eyes were less 
oblate for all radial distances from the 
apex (Fig. 3); the difference was statisti-
cally significant only within the inner 3.5 
mm of the cornea (Q10 and Q15).
As shown in Figure 1, the Q-factor 
adjustment consists of a kind of addi-
tional correction in the midperiphery of 
the cornea, resembling a hyperopic cor-
rection. To avoid such consecutive hy-
peropic correction, the central part must 
be treated by means of a photothera-
peutic keratectomy, which enhances the 
central ablation depth as previously 
described. 124 An intended change in Q-
factor ∆Q of -0.6 within an optical zone 
of 6.5 mm requires 28.5 µm more central 
tissue removal (Fig. 1). This increased 
central keratectomy depth may limit the 
application of Q-factor optimized abla-
tion to corrections of only mild to mod-
erate myopia. A stronger attempted 
asphericity correction, for example, a 
target Q of -1.0, might have yielded 
more prolate postoperative corneas, 
but, on the other hand, such a strong Q-
factor correction would increase the 
central keratectomy depth by another 
30 µm, which we judged not to be ap-
propriate with respect to the already 
well-preserved low-contrast visual acu-
ity data in this study. 
This study is limited regarding the 
short follow-up of only 1 month. We 
intended to present early postoperative 
data because the corneal optics may be 
affected by stromal and epithelial heal-
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ing. Nevertheless, it would be interest-
ing to observe whether corneal optics 
have some regression. Also, eyes with 
high preoperative wavefront errors of 
higher order (at least of the nondomi-
nant eye) were excluded from the study. 
Those eyes, however, should be treated 
by wavefront-guided customized abla-
tion anyway.
In summary, this study demonstrated 
that a Q-factor optimized ablation pro-
file yielded visual, optical, and refractive 
results comparable to those of the 
wavefront-guided customized tech-
nique for corrections of myopia up to -9 
D. A significantly better result in corneal 
optics, however, was obtained only with 
corrections up to -5 D. The Q-factor op-
timized ablation represents a custom-
ized approach that is much less time 
consuming than the wavefront-guided 
technique since it is based on preopera-
tive corneal topography, which is man-
datory in any case to detect keratectatic 
disorders. 
The Q-factor optimized profile has, 
therefore, the potential to replace cur-
rently used standard profiles for correc-
tions of myopic astigmatism.
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3.4
Clinical Photoablation With a 500-Hz Scanning
Spot Excimer Laser 
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Abstract
Objective. The aim of this study was to use a 500-Hz scanning spot laser (Con-
cept500, Wavelight Laser Technologie AG, Erlangen, Germany) to investigate poten-
tial side effects that might be associated with the use of a high repetition rate laser 
platform.
Methods. Seven eyes were treated using a 500-Hz scanning spot laser for laser in situ 
keratomileusis (LASIK). The local frequency of the ablation was kept below 40 Hz to 
avoid local heating of corneal tissue. With the exception of the high repetition rate 
(500 Hz), all other laser parameters such as fluence, algorithm, ablation profile, and 
spot diameter were identical to a standard Wavelight Allegretto laser system. Pa-
tients were examined at 1 month and 1 year after initial treatment. Preoperative and 
postoperative examination included manifest sphere and cylinder, uncorrected and 
best spectacle-corrected visual acuity (BSCVA).
Results. All eyes were treated for myopia or myopic astigmatism. Five eyes received 
spherocylindrical and two eyes spherical ablation only. No adverse events correlated 
with the use of a high repetition rate laser system were observed during surgery or at 
any point during follow-up. All eyes maintained or had improved BSCVA at 12 
months after treatment when compared to preoperative values.
Conclusions. The use of an excimer laser wit a maximal repetition rate of 500 Hz 
and a local repetition rate of less than 40 Hz was free of any specific side effect that 
might be associated with the use of such a high repetition rate.
Iseli HP, Mrochen M, Hafezi F, Seiler T.
J Refract Surg 2004; 20(6):831-834
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Introduction
Customized laser surgery with scan-
ning spot lasers allows adjustment of 
spherical or cylindrical aberrations, but 
also aberrations of higher order and in 
detail, irregular astigmatism. Data ob-
tained from wavefront analysis or cor-
neal topography may be used to estab-
lish more complex ablation profiles 
compared to the simple ablation profiles 
used in sphero-cylindrical corrections. 29, 
31, 118, 133-137 
Besides precise measurement of the 
wavefront, the success of such a proce-
dure depends on the way in which the 
ablation profile is transferred onto the 
cornea. Here, two additional parameters 
play a vital role-beam diameter and 
speed of treatment. 
The beam diameter 109, 138, 139 is a key 
parameter to provide correction of 
higher order aberrations. A small diame-
ter enables the surgeon to reshape the 
cornea by applying a complex ablation 
profile. However, the use of such a small 
laser spot demands fast eye tracking, 
accurate scanning mirrors, and highly 
stable excimer lasers. In addition, laser 
treatment should be performed within 
30 to 60 seconds because the cornea 
might dry and the fixation ability of the 
patient might decrease when treatment 
time is too long. Therefore, smaller laser 
spots need higher repetition rates to 
avoid these effects. On the other hand, a 
high repetition rate might induce an 
increased temperature load to the tis-
sue. 
The aim of this pilot study was to in-
vestigate potential clinical side effects 
related to the use of a high repetition 
rate. Such thermal side effects could 
manifest as increased inflammation in 
the early postoperative period, opacities 
in the interface, and irregularities as 
detected in corneal topography. 
Patients and methods
Patients
A prospective study of LASIK with a 
high repetition rate laser system for 
myopia and astigmatism was initiated. 
There were seven males (three right 
eyes, four left eyes) who ranged in age 
from 30 to 40 years (mean age 35 years). 
Inclusion criteria were patient age 21 
years, manifest refraction less than 
-12.00 diopters (D) in sphere and less 
than 4.00D in cylinder, stable manifest 
refraction over the previous 2 years, the 
pupil of the eye treated was not de-
formed, the patient agreed to partici-
pate in the study, and to attend follow-
up examinations for up to 1 year after 
surgery. Informed consent was obtained 
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from all patients after a thorough expla-
nation of the procedure and its potential 
risks. The institutional review board of 
the University eye clinic approved this 
pilot study.
Patients were excluded from the study 
if they had a systemic or ocular disease 
likely to influence corneal healing, a 
history of glaucoma, retinal disorders 
that might limit visual acuity (e.g., my-
opic maculopathy) or complicate the 
LASIK procedure (e.g., equatorial degen-
erations), previous ocular surgery, or 
suffered from dry eyes substantiated by 
a pathologic Schirmer test. One eye with 
amblyopia (the first eye in this pilot 
study) and a best spectacle-corrected 
visual acuity (BSCVA) of 20/30 was in-
cluded in the series. Contact lens use 
was ceased 2 weeks before preoperative 
examination.
Clinical Examinations
The following examinations were per-
formed: uncorrected (UCVA) and best 
spectacle-corrected (BSCVA) visual acu-
ity (Snellen visual acuity chart), corneal 
topography (Topolyzer, Wavelight Laser 
Technologie AG, Erlangen, Germany), 
applanation tonometry, pachymetry, 
slit-lamp microscopy of the anterior 
segment, and contact lens ophthalmos-
copy of the posterior segments. Patients 
were examined at 1 day, 1 month, and 
12 months after surgery. 
At the day 1 postopera-
tive examination only, 
UCVA, BSCVA, and slit-
lamp microscopy were 
per formed (data not 
shown). Preoperative 
spherical equivalent re-
fraction ranged from 
-0.35 to -9.75 D, and 
astigmatism ranged from 
0 to 3.50 D: between 0 and -0.99 D in 
two eyes, -3.00 to -3.99 D in two eyes, 
-4.00 to -4.99 D in two eyes, and -5.00 to 
-5.99 D in one eye; cylinder was between 
0 and 1.00 D in three eyes, 1.00 to 2.00 D 
in three eyes, and 3.00 to 4.00 D in one 
eye.
Surgery
All LASIK procedures were performed 
between September and December 
2001 under topical anaesthesia (pro-
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paracaine 0.5%). First, a flap with a di-
ameter of 9.0 mm and a thickness of 
approximately 130 μm was created with 
a superior hinge, using a Supratome 
microkeratome (Schwind Eye-Tech-
Solution, Kleinostheim, Germany).
Ablation
Laser treatments were performed 
using a 500-Hz scanning spot laser sys-
tem (Concept500, Wavelight Laser Tech-
nologie AG, Erlangen, Germany). A 
Gaussian beam profile with truncated 
wings was used to re-
duce thermal load of the 
surrounding tissue by 
sub-threshold laser en-
ergy. The ablation di-
ameter of a single spot at 
the cornea was 0.9 mm. 
The mean radiant expo-
sure was 0.2 J/cm2. The 
scanning program was 
adjusted to provide a 
local repetition rate of 40 Hz or less. The 
sampling rate of the video-based eye 
tracker was 500 Hz, thus reducing the 
latency between registration of the eye 
position and mirror alignment to ap-
proximately 4 ms. (The eye tracking 
frequency and the repetition rate of the 
laser were both 500 Hz; each treatment 
point on the cornea was treated at a 
maximum 40 times per second.) Auto-
matic pupil detection allowed accurate 
centering of the treatment zone. During 
treatment, the patient was advised to 
concentrate on a fixation target 
mounted coaxially to the optical axis of 
the laser system. In all treatments, the 
ablation zone was 6.5 mm and the over-
all treatment zone was 7.2 mm in diame-
ter. Treatment time was less than 5 sec-
onds per diopter of myopia. After pho-
toablation, the flap was repositioned 
and the interface was rinsed with bal-
anced salt solution. A bandage lens 
soaked in ofloxacine 0.5% solution was 
applied for the first night after surgery. 
Fluorometholon drops 0.1% were used 
twice daily for 1 week. 
All treatments were based on mani-
fest refraction with target refraction in 
all eyes of plano, except one eye for 
which the target refraction was -0.75 D. 
Nomogram adjustments were not ap-
plied in this study. Preoperative calibra-
tion tests of the laser system included 
energy measurements, laser beam pro-
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filing, ablation of test target, scanning 
mirror alignment check (checkerboard 
pattern ablation on test target), and 
testing of the optical alignment of the 
fixation light and the video eye tracker. 
Clinical results were analyzed regarding 
safety, efficacy, and predictability after 
follow-up at 1 and 12 months. 
Results
All operations were uneventful. All 
corneas remained clear during and after 
photoablation. Slit-lamp microscopy 
revealed no signs of corneal opacities 
and/or thermal damage in the interface 
immediately after surgery or at any 
postoperative examination. On the first 
postoperative day, UCVA was 20/40 or 
better in all eyes. Follow-up examina-
tions were performed at 1 and 12 
months after surgery. 
Safety was evaluated by maintenance 
of BSCVA. All eyes had stable or better 
BSCVA 12 months after surgery when 
compared to preoperative values (Table 
1). The first eye of the cohort was am-
blyopic with a BSCVA of 20/40 before 
surgery; at 1 month after surgery, BSCVA 
was 20/50, and at 12 months after sur-
gery, 20/30. No irregularities were de-
tected in corneal topography at any 
examination beyond the first postopera-
tive day. 
At 12 months, all eyes achieved UCVA 
of 20/40 or better. Four of seven eyes 
had 20/20 or better, with one eye inten-
tionally undercorrected to -0.75 D and 
one eye amblyopic. 
At 12 months after surgery, mean 
spherical equivalent refraction in all eyes 
did not exceed ±1.00 D (Table 2); five of 
seven eyes (71.4%) were within ±0.50 D. 
Cylinder was reduced to less than -1.00 
D in all eyes.
Discussion
The purpose of this study was to in-
vestigate possible clinical side effects 
that might be associated with use of a 
high repetition rate excimer laser for 
laser vision correction. Our results dem-
onstrate that the use of repetition rates 
as high as 500 Hz did not affect the clini-
cal outcomes of LASIK procedures. None 
of the operated eyes showed an adverse 
reaction that could be related to the 
higher repetition rate of the laser. 
Although ultraviolet photoablation 
with the ArF excimer laser is a “cold abla-
tion,” the temperature rises above 200°C 
within several nanoseconds. 140 Bende 
and co-workers found a mean in situ 
temperature increase in tissue surround-
ing the ablation area of approximately 
8°C. 141 Similar results have been pub-
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lished by Maldonado-Codina and col-
leagues 142 and by Betney and col-
leagues. 143 Excimer laser platforms usu-
ally work with a repetition rate of 10 to 
50 Hz and a radiant exposure (fluence) 
of approximately 0.2 J/cm2; this results 
in an average power on the corneal sur-
face of approximately 0.8 to 3.8 W, as-
suming a typical treatment zone of 6.0 
to 7.0 mm in diameter. In principle, the 
total energy (sum of all laser spots ap-
plied) needed to remove the same 
amount of tissue with smaller scanning 
spots should be the same as when using 
larger spots. The energy of a single laser 
pulse used in our study was approxi-
mately 2 mJ at a mean radiant exposure 
of 0.2 mJ/cm2. The scanning algorithm 
of the Concept500 laser takes into con-
sideration that the local frequency 
should be below 40 Hz. Thus, the laser 
spots (0.9-mm diameter) are distributed 
systematically within the 6.0- to 
7.0-mm-diameter treatment zone. The 
resulting average power distributed 
within the treatment zone is almost 
identical to the power distribution in 
standard laser systems. Consequently, 
one might not expect a significantly 
higher thermal load during corneal laser 
surgery with a high repetition rate laser 
system. 144
Laser in situ keratomileusis is widely 
accepted as a safe procedure for correc-
tion of refractive errors. Remarkable 
improvements have been made by the 
introduction of customized laser 
ablation-superior to conventional 
photoablation-by including correction 
of higher order optical aberrations. 
A recent study by Huang and Arif 109 
showed that, based on fundamental 
considerations with currently used 
beam diameters of 1.0 mm and less, it 
should be possible to eliminate most 
higher order optical aberrations in a 
normal eye. Thus, current laser technol-
ogy should be adequate for corneal 
reshaping in the majority of cases. How-
ever, the quality of the correction de-
clines steadily as beam size increases. 138 
Therefore, customized photoablation 
may require additional reduction in laser 
spot size to enable finer and more com-
plex ablation profiles in highly aberrated 
eyes or in eyes with local irregularities 
such as steep central islands. 109
In contrast, reducing the spot size for 
customized ablation has a distinct effect 
on other technical parameters, such as 
the eye tracking system. Bueeler and 
colleagues 138 studied the effect of vari-
ous laser parameters on the optical out-
come of photorefractive procedures. 
Numerical simulations of the entire abla-
tion process were performed on a 
schematic model eye by varying abla-
tion depth per pulse, laser spot size, eye 
tracker latency, and magnitude of refrac-
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tive correction. They showed unambi-
guously that contrast transfer decreased 
significantly with increased latency of 
the eye tracker. For constant laser and 
tracking parameters, this decrease was 
more significant for higher myopic cor-
rections. Treatments performed with 
smaller spot sizes and smaller ablation 
depths per pulse were more sensitive to 
tracking latency. Assuming defined eye 
tracker latency, the most stable results 
were obtained for large beam diameters 
and high central ablation depths per 
pulse. However, a tracking latency below 
10 ms would allow for a reduction of the 
beam diameter to 0.50 mm. In our study, 
treatments were performed with a 500-
Hz scanning spot laser with a spot size 
of 0.9 mm. Latency was on the order of 4 
ms, ensuring an optimized balance be-
tween spot size and eye tracker per-
formance. 
In addition to its influence on the 
aforementioned technical parameters, 
reducing the spot diameter systemati-
cally increases the number of laser 
pulses. In brief, the number of laser 
pulses that must be applied for a myopic 
correction increases with the decrease 
of the square of the spot diameter. Abla-
tion time should not exceed 60 seconds 
because of possible corneal drying or 
decrease in the patient's concentration 
during the treatment. A minimal abla-
tion zone of 6.0 mm, small spot size <0.5 
mm, and a limited treatment time might 
require a much faster scanning spot 
laser, superior to current commercially 
available systems. 
In our pilot series of seven eyes, the 
use of the 500-Hz excimer laser did not 
reveal any specific clinical side effects 
potentially associated with the use of a 
high repetition rate. New laser systems 
equipped with high repetition rates may 
facilitate customized treatments with 
smaller laser spots (diameter <0.9 mm) 
for highly aberrated eyes that cannot be 
treated with currently available systems.
3.4 500-Hz scanning spot
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Summary
Management of 
complications in 
refractive laser surgery
The first part of this thesis focuses on 
the management of complications in 
refractive laser surgery:
Reoperations after LASIK surgery
The frequency of refractive surgery 
has increased drastically in the past 
years. In analogy, the incidence of reop-
erations after LASIK surgery has followed 
this trend. In Chapter 2.1, we have ana-
lyzed all reoperations performed at our 
institute over the period of one year. The 
majority of reoperations is performed as 
LASIK surgery with re-lift of the primary 
flap, which is now seen as an easy-to-
perform and safe procedure. The main 
indications for reoperations are residual 
astigmatism and increased patient’s 
expectations in slight under- or overcor-
rection.
Customized ablation algorithm for 
the treatment of steep central islands 
after refractive laser surgery
Most of the technical advances in re-
fractive laser surgery were only achieved 
in the past few years and many patients 
who were treated earlier show previous 
optical complications such as small opti-
cal zones, decentered ablations and for-
mation of steep central islands. The lat-
ter often remains as an unresolved the-
rapeutical problem with current laser 
ablation profiles. In Chapter 2.2, we 
present a new ablation strategy to cor-
rect for steep central islands after previ-
ous photorefractive keratectomy (PRK) 
and laser in situ keratomileusis (LASIK).
Anterior lamellar keratoplasty with 
a microceratome: a method for ma-
naging complications after refractive 
surgery
In 1999, the frequency of refractive 
laser surgery had exceeded that of cata-
ract surgery in the USA by a factor of 2 
and had become the most frequently 
performed procedure in ophthalmology. 
In the years thereafter, a significant in-
crease in the total number of postopera-
tive complications was noted. Many of 
these complications affect the anterior 
corneal stroma such as severe scarring 
after PRK, cutting errors and recurrent 
epithelial ingrowth after LASIK. In cases 
where the posterior corneal stroma is 
intact, lamellar keratoplasty is the pro-
cedure of choice. Up to now, the prepa-
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ration of the donor lamella and the re-
cipient wound bed were performed 
manually leading to some degree of 
irregular corneal surface even with expe-
rienced surgeons. In Chapter 2.3, we 
present the first results of automated 
anterior lamellar keratoplasty. This new 
technique combines the known tech-
nique of superficial lamellar keratoplasty 
with the automated preparation of the 
donor lamella. The recipient wound bed 
uses microceratomes originally devel-
oped for LASIK. The advantages of this 
technique are a more uniform donor 
and recipient match, the possibility of 
postoperative correction of irregular 
astigmatism performing a re-lift of the 
flap, and customized ablation.
Small optical zones after PRK for high 
myopia are also often observed compli-
cations of procedures performed in the 
“early days” of refractive laser surgery. 
Many of the former refractive patients 
who were treated in the late 1980s and 
early 1990s are seeking help from re-
cently developed techniques such as 
customized ablations. However, many 
patients presenting with small optical 
zones have residual myopia combined 
with critically low central corneal thick-
ness and beginning presbyopia. In 
Chapter 2.4 we present a 2-step tech-
nique that we have developed for the 
treatment of such cases. In a first step, a 
clear lens exchange shifts the patient to 
hyper-opia. After this procedure, the 
calculation of a topography-based abla-
tion profile shows that ablation in the 
central cornea will be minimal, enabling 
the surgeon to perform a customized 
topography-guided treatment.
Corneal collagen cross-linking by 
UVA/riboflavin (X-linking) represents a 
recently developed method for the 
treatment of progressive keratoconus. In 
Chapter 2.5 we demonstrate that the 
effect of crosslinking on the cornea can 
be identified as soon as several weeks 
after treatment by identifcation of a 
stromal demarcation line. In Chapter 2.6 
we investigated whether this technique 
would also arrest iatrogenic keratecta-
sia after LASIK. With a postoperative 
follow-up time of up to 20 months we 
demonstrated that X-linking slows 
down, arrests and even partially reverses 
the progression of LASIK-induced iatro-
genic keratectasia.
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Prevention of 
complications in 
refractive laser surgery
The second part of this thesis dis-
cusses strategies for the prevention of 
complications in refractive laser surgery:
Ablation profiles in corneal laser 
surgery: current and future concepts
The preoperative calculation and 
choice of the appropriate ablation pro-
file represent a central element for the 
quality and predictability of results in 
corneal refractive laser surgery. 
In Chapter 3.1 we describe past, cur-
rent and potential future ablation pro-
files. Ablation profiles may either be 
based on the entire optics such as the 
classic Munnerlyn profile used for almost 
20 years and the recently introduced 
wavefront-optimized and wavefront-
guided profiles. Ablation profiles may 
also be based on the cornea solely such 
as topography-guided or Q factor-
adjusted profiles. Future ablation pro-
files (“ray tracing”) might  incorporate 
topographic, aberrometric and biomet-
ric data to establish an even more accu-
rate ablation profile. Each eye should be 
carefully examined prior to surgery and 
the best-suited profile should be evalu-
ated for the individual eye.
Wavefront-guided customized abla-
tion profiles are currently the most fre-
quently used profiles in corneal refrac-
tive laser surgery. A number of factors 
influence the safety, efficacy and pre-
dictability of such treatments. These 
factors include correct centration during 
measurement of the wavefront, proper 
wavefront sensing and transfer of the 
wavefront measurement into an abla-
tion profile. This step consists of three 
phases: inversion of the wavefront map, 
conversion of the wavefront map and 
offset for the ablation profile. The differ-
ent phases and potential sources of error 
are discussed in Chapter 3.2.
A yet unresolved issue in refractive 
laser surgery is management of laser 
correction in presbyopia. Many presby-
opic patients do not only seek to be 
independent of glasses or contact lenses 
for distant but also for near vision. 
Monovision has been offered by many 
surgeons as an alternative to reading 
glasses. However, this method of aiming 
at emmetropia on the dominant eye and 
leaving minor myopia on the non-domi-
nant eye is not always tolerated well and 
shows some major disadvantages such 
as reduced stereo vision as well as glare 
and halos on the non-dominant eye. 
Q factor-adjusted ablation profiles 
were developed only recently and repre-
sent a promising alternative to wave-
front-guided profiles. The Q factor is a 
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shape factor that characterizes the as-
phericity of the human cornea. Chang-
ing the peripheral corneal asphericity to 
a more prolate form (Q factor) might be 
a means to induce better near visual 
acuity while at the same time keeping 
good far visual acuity. In Chapter 3.3 we 
compare patients that have been trea-
ted using Q factor-adjusted ablation 
profiles with patients treated by wave-
front-guided profiles and analyze the 
outcomes.
The speed by which a laser treatment 
can be performed is an essential step in 
the predictability of a refractive laser 
surgery procedure. The tissue ablation 
performed by a single laser spot is calcu-
lated based on a certain degree of cor-
neal dehydration. 
Once the flap is lifted in LASIK surgery, 
corneal hydration might shift and 
change within seconds to minutes. Thus, 
the faster tissue ablation occurs, the 
more accurate the result will be. 
Whereas first-generation scanning spot 
excimer lasers performed photoablation 
at rates of 50 to 200 Hz, the newest pro-
totypes show repetition rates of up to 
500 Hz. In Chapter 3.4 we investigated 
potential side effects that might be as-
sociated with the use of such a high 
repetition rate laser platform.
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Samenvatting
Behandeling van com-
plicaties van 
refractiechirurgie met 
de laser
Het eerste gedeelte van dit proefschrift 
gaat over de behandeling van complica-
ties van refractiechirurgie met de laser:
Re-operaties na LASIK chirurgie
De frequentie waarmee refractiechi-
rurgie wordt toegepast is de laatste jaren 
enorm toegenomen. Analoog hieraan 
heeft de incidentie van re-operaties na 
LASIK-chirurgie deze trend gevolgd. In 
hoofdstuk 2.1 hebben we alle re-
operaties geanalyseerd, die in de periode 
van één jaar in ons instituut zijn verricht. 
Het merendeel van de re-operaties wordt 
verricht door LASIK-chirurgie via een re-
lift van de primaire flap, wat nu wordt 
beschouwd als een gemakkelijk uit te 
voeren en veilige ingreep. De belangrijk-
ste indicaties voor re-operaties zijn 
resterend astigmatisme en het toege-
nomen verwachtingspatroon van de 
patiënt ten aanzien van geringe onder- 
en overcorrectie.
Maatwerk ablatie-algoritme voor de 
behandeling van steep central islands 
na refractiechirurgie met de laser
De grootste technische vooruitgang bij 
refractiechirurgie met de laser is pas in 
de laatste jaren bereikt en veel patiënten 
die in de periode hiervoor zijn behandeld 
hebben optische complicaties zoals 
kleine optische zones, gedecentreerde 
ablaties en vorming van steep central 
islands. Deze laatste complicatie blijft 
ook met de huidige schema’s voor laser-
ablatie moeili jk behandelbaar. In 
hoofdstuk 2.2 wordt een nieuwe laser 
ablatie strategie voor de behandeling 
van steep central islands na eerdere fo-
torefractieve keratectomie (PRK) en laser 
in situ keratomileusis (LASIK) besproken. 
Anterieure lamellaire keratoplastiek 
met een microtoom: een methode 
voor behandeling van complicaties na 
refractiechirurgie
In 1999 was de frequentie van refrac-
tiechirurgie met de laser in de Verenigde 
Staten twee keer zo hoog als die van 
cataractchirurgie; daarmee is het de 
meest uitgevoerde oogheelkundige in-
greep geworden. In de jaren hierna ont-
stond een sterke toename van het aantal 
postoperatieve complicaties. Veel van 
deze complicaties betrof het voorste 
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stroma, zoals ernstige littekenvorming na 
PRK, snijfouten, en terugkerende 
epitheel-ingroei na LASIK. In gevallen 
waarbij het achterste deel van het stroma 
intact is, geniet een lamellaire kerato-
plastiek de voorkeur. Tot voor kort werd 
de donorlamel en het wondbed van de 
recipiënt manueel geprepareerd, het-
geen zelfs bij ervaren chirurgen leidde 
tot een wisselende mate van irregulair 
cornea-oppervlak.  In hoofdstuk 2.3 
worden de eerste resultaten behandeld 
van geautomatiseerde anterieure la-
mellaire keratoplastiek. 
Deze nieuwe techniek combineert de 
bestaande techniek van superficiële la-
mellaire keratoplastiek met automatische 
preparatie van de donorlamel en het 
recipiënt wondbed door middel van mi-
crotomen, die ontwikkeld waren voor 
LASIK. De voordelen van deze techniek 
zijn een betere match tussen donor en 
recipiënt en de mogelijkheid van post-
operatieve correctie van irregulier astig-
matisme via een re-lift van de flap en 
maatwerk ablatie. Vorming van kleine 
optische zones na PRK voor hoge myopie 
is een andere, veel voorkomende com-
plicatie van ingrepen uit de ’vroege peri-
ode’ van de refractiechirurgie, eind jaren 
1980 en begin jaren 1990. Veel patiënten, 
behandeld in deze periode, zoeken hun 
toevlucht tot recent ontwikkelde tech-
nieken zoals maatwerk ablaties. Vele 
patiënten met kleine optische zones 
hebben resterende myopie gecombi-
neerd met een kritisch geringe centrale 
cornea-dikte en beginnende presbyopie. 
In hoofdstuk 2.4 presenteren we een 
twee-staps techniek, die speciaal voor 
de behandeling van zulke patiënten ont-
wikkeld werd. In de eerste stap leidt een 
clear lens exchange tot hyperopie van het 
behandelde oog. Nadien laat een calcula-
tie van een op topografie gebaseerd 
ablatie-profiel zien dat ablatie van de 
centrale cornea minimaal zal zijn, zodat 
de chirurg een behandeling kan uitvo-
eren, aan de hand van topografische 
bevindingen. 
Corneale collageen cross-linking door 
UVA/riboflavine (X-linking) is een recent 
ontwikkelde methode voor de behan-
deling van progressieve keratoconus. In 
hoofdstuk 2.5 laten we zien dat het ef-
fect van cross-linking op het hoornvlies al 
binnen enkele weken na behandeling 
kan worden vastgesteld door de identifi-
catie van een stromale demarcatie-lijn. In 
hoofdstuk 2.6 onderzochten we of deze 
techniek ook de iatrogene progressieve 
keratectasie na LASIK zou kunnen laten 
stoppen. Met een postoperatieve follow-
up tot 20 maanden na behandeling laten 
we zien dat X-linking de progressie van 
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LASIK-geïnduceerde iatrogene ker-
atectasie vertraagt, stopzet, of zelfs 
ongedaan maakt.
Preventie van compli-
caties van refractiechi-
rurgie met de laser
Het tweede gedeelte van dit proef-
schrift behandelt strategieën voor de 
preventie van complicaties van refrac-
tiechirurgie met de laser:
Ablatie-profielen in de chirurgie van 
de cornea met de laser: huidige en 
toekomstige concepten
De preoperatieve calculatie en keuze 
van optimaal ablatieprofiel zijn essentieel 
voor de kwaliteit en voorspelbaarheid 
van resultaten van corneale refractieve 
laser chirurgie.
In hoofdstuk 3.1 beschrijven we oude, 
huidige en potentieel toekomstige 
ablatie-profielen. Ablatie-profielen kun-
nen ofwel gebaseerd zijn op de totale 
optiek zoals bij het klassieke Munnerlyn-
profiel, dat gedurende bijna 20 jaar ge-
bruikt werd, ofwel op recent geïntro-
duceerde wave-front-optimized en wave-
front-guided profielen. Ablatie-profielen 
kunnen ook gebaseerd worden op alleen 
het hoornvlies, zoals bij de topografie-
gestuurde of Q-factor-aangepaste profie-
len. Toekomstige ablatie-profielen (ray-
tracing) zouden topographische, aber-
rometrische en biometrische data kun-
nen incorporeren voor een grotere accu-
ratesse. Elk oog zou preoperatief nau-
wkeurig onderzocht moeten worden, 
waarbij het meest geschikte ablatiepro-
fiel wordt bepaald. 
Wavefront-guided maatwerk ablatie-
profie-len zijn de meest toegepaste pro-
fielen in de refractiechirurgie met de 
laser van het hoornvlies. Een aantal fac-
toren beïnvloedt de veilig-heid, doeltref-
fendheid en voorspelbaarheid van zulke 
behandelingen. Deze factoren bestaan 
uit correcte centratie tijdens meting van 
de wavefront, adequate wavefront sens-
ing en omzetting van een wavefront 
meting in een ablatieprofiel. Deze stap 
bestaat uit 3 fasen: inversie van een 
wavefront-kaart, conversie van een 
wavefront-kaart en offset voor een abla-
tieprofiel. De verschillende fasen en po-
tentiële oorzaken van fouten worden 
behandeld in hoofdstuk 3.2. 
Een nog niet opgeloste kwestie bij de 
refractiechirurgie met de laser is de be-
handeling van refractie-problemen bij 
patiënten met presbyopie. Veel presby-
ope patiënten willen zowel voor ver als 
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dichtbij zien niet langer afhankelijk zijn 
van bril of contactlenzen. Monovision 
wordt door vele chirurgen aangeboden 
als alternatief voor de leesbril. Hierbij is 
het dominante oog emmetroop (ge-
maakt) en het niet-dominante oog ger-
ing myoop (gemaakt). Monovision wordt 
echter niet door een ieder goed verdra-
gen en heeft als belangrijke bijwerking 
een gereduceerd stereozien, evenals 
glare- en halo-klachten van het niet-
domi-nante oog. 
Q-factor-adjusted ablatie-profielen 
werden recent ontwikkeld en zijn een 
veelbelovend alternatief voor wave-
front-guided profielen. De Q-factor is een 
factor die de asfericiteit van de cornea 
aangeeft. Verandering van de de perifere 
corneale asfericiteit naar een plattere 
vorm (Q-factor) zou een een middel kun-
nen zijn om beter nabij zien te verkrijgen 
met behoud van goed veraf zien. In 
hoofdstuk 3.3 vergelijken we patiënten 
die behandeld zijn met Q-factor-adjusted 
ablatieprofielen met anderen die behan-
deld werden met wave-front-guided 
profielen. Ook evalueren we de resul-
taten.
De snelheid waarmee een laserbehan-
deling kan worden verricht is belangrijk 
voor de voorspelbaarheid van de resul-
taten van refractiechirurgie met de laser. 
De weefsel-ablatie ten gevolge van een 
enkele laser spot is afhankelijk van de 
mate van corneale hydratie. Als de flap 
wordt opgetild in LASIK-chirurgie kan de 
hydratiegraad van de cornea binnen 
enkele seconden tot enkele minuten 
veranderen. Daarom zal met een snellere 
behandeling een betrouwbaarder resul-
taat verkregen kunnen worden. Terwijl 
de eerste-generatie scanning spot exci-
mer lasers foto-ablatie verrichten met 
frequenties van 50 tot 200 Hz, is de fre-
quentie bij de laatste prototypen wel 500 
Hz. In hoofdstuk 3.4 onderzochten we 
de potentiële bijwerkingen die kunnen 
ontstaan bij gebruik van deze hoge-
frequentie lasersystemen.
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